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ABSTRACT 
 Titanium dioxide (TiO2) nanomaterial use is becoming more 
prevalent as is the likelihood of human exposure and environmental 
release.  The goal of this thesis is to develop analytical techniques to 
quantify the level of TiO2 in complex matrices to support environmental, 
health, and safety research of TiO2 nanomaterials.   
A pharmacokinetic model showed that the inhalation of TiO2 
nanomaterials caused the highest amount to be absorbed and distributed 
throughout the body.  Smaller nanomaterials (< 5nm) accumulated in the 
kidneys before clearance.  Nanoparticles of 25 nm diameter accumulated 
in the liver and spleen and were cleared from the body slower than smaller 
nanomaterials. 
 A digestion method using nitric acid, hydrofluoric acid, and 
hydrogen peroxide was found to digest organic materials and TiO2 with a 
recovery of >80%.  The samples were measured by inductively coupled 
plasma-mass spectrometry (ICP-MS) and the method detection limit was 
600 ng of Ti. 
 An intratracheal instillation study of TiO2 nanomaterials in rats 
found anatase TiO2 nanoparticles in the caudal lung lobe of rats 1 day 
post instillation at a concentration of 1.2 µg/mg dry tissue, the highest 
deposition rate of any TiO2 nanomaterial.  For all TiO2 nanomaterial 
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morphologies the concentrations in the caudal lobes were significantly 
higher than those in the cranial lobes.   
 In a study of TiO2 concentration in food products, white colored 
foods or foods with a hard outer shell had higher concentrations of TiO2.  
Hostess Powdered Donettes were found to have the highest Ti mass per 
serving with 200 mg Ti.  As much as 3.8% of the total TiO2 mass was able 
to pass through a 0.45 µm indicating that some of the TiO2 is likely 
nanosized.   
 In a study of TiO2 concentrations in personal care products and 
paints, the concentration of TiO2 was as high as 117 µg/mg in Benjamin 
Moore white paint and 70 µg/mg in a Neutrogena  sunscreen.  Greater 
than 6% of Ti in one sunscreen was able to pass through a 0.45 µm filter.  
The nanosized TiO2 in food products and personal care products may 
release as much as 16 mg of nanosized TiO2 per individual per day to 
wastewater.   
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CHAPTER 1: INTRODUCTION 
1.1 NANOTECHNOLOGY BACKGROUND INFORMATION 
A nanomaterial is generally defined to have at least one dimension 
that measures less than 100 nm.  Nanomaterials often have novel 
physicochemical properties different than their bulk material counterparts 
due to their small nature and large surface area to volume ratio.  
Nanotechnology has developed in the last two decades as a discipline 
concerned with deriving advantages from the special properties of 
nanomaterials. [1] Nanotechnology was a $10 billion industry in 2010 and 
forecasters predict that the industry will grow to $1 trillion by 2015. [2] 
Nanomaterials can be naturally occurring or manmade and can be carbon 
based or created from metals and metal oxides like titanium dioxide 
(TiO2). 
The opportunities that nanotechnologies create span a wide range 
of disciplines.  Nanomaterials have been touted as a means to create 
molecular machines, provide clean water to those without access, and 
revolutionize the health care industry. [3-6] Though the applications of 
nanotechnology seem limitless, many experts warn that a more thorough 
investigation needs to be conducted into the health and environmental 
risks associated with nanomaterials.  As David Warheit, chairman of the 
task force on “Health and Environmental Safety of Nanomaterials” for the 
European Centre for Ecotoxicology and Toxicology of Chemicals put it, 
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“The number of implication studies has not caught up with the number of 
application studies.” [7] The need for more implication studies continues to 
grow as the uses of nanomaterials continue to grow.  This is especially 
true for one of the most commonly use nanomaterials, TiO2. 
1.2 TITANIUM DIOXIDE NANOMATERIALS 
 As a bulk material, TiO2 is primarily used as a pigment because of 
its brightness, high refractive index, and resistance to discoloration.  
Nearly 70% of all TiO2 produced is uses as a pigment in paints, but it is 
also used as a pigment in glazes, enamels, plastics, paper, fibers, foods, 
pharmaceuticals, cosmetics, and toothpastes. [8] However, recently more 
attention is being given to the applications of TiO2 as a nanomaterial.  In 
2005 the global production of nanoscale TiO2 was estimated to be 2000 
metric tons worth $70 million. [9] By 2010 the production had increased to 
5000 metric tons and is expected to continue to increase till 2025. [10]  
 Production of TiO2 materials produces a range of primary particles 
sizes.  Most applications of TiO2 would benefit more from smaller primary 
particle sizes, and the percentage of TiO2 that is produced to be closer to 
the nanosized range is expected to increase exponentially. [11] This shift 
in production to materials with a smaller primary particle size is the 
increase of TiO2 “nanomaterial” production. TiO2 nanomaterial is an ill-
defined term that is often interchanged with TiO2 nanoparticle.  TiO2 
nanoparticles are generally synthesized to have a crystalline structure.  
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When TiO2 nanoparticles are created they can be amorphous or from into 
some mix of three different crystal structures: anatase, rutile, and brookite.  
Each of these crystal structures has its own unique properties. [12] The 
most common procedure for synthesizing TiO2 nanoparticles utilizes the 
hydrolysis of titanium (Ti) salts in an acidic solution. [13] The structure, 
size, and shape of the TiO2 nanoparticles can be controlled by using 
chemical vapor condensation or nucleation from sol gel. [14, 15] TiO2 can 
also be formed into nanowires or nanotubes. [16, 17] Thus, nanomaterial 
is an umbrella term that actually encompasses nanoparticles, nanowires, 
nanotubes, or other morphology all with different sizes, shapes, and 
structures. 
1.3 APPLICATIONS OF TITANIUM DIOXIDE NANOMATERIALS 
1.3.1 UV protection and opacity.  One unique property of TiO2 
nanomaterials is an increased ability to disperse light which makes them 
an ideal ingredient in sunscreens and cosmetics to protect the skin against 
harmful ultraviolet (UV) rays. [9, 18, 19] A large portion of the nanosized 
TiO2 produced ends up as personal care products like sunscreen and 
cosmetic creams.  As stated before, bulk TiO2 is often used as a bright 
white pigment.  However, TiO2 nanomaterials tend to be good opacifiers 
and are used in paints and coatings.[20, 21] 
1.3.2 Water treatment and remediation.  The photocatalytic 
properties of TiO2 nanomaterials are often used in water treatment 
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applications.  The high surface area per unit mass creates a larger 
catalytic surface for the production of hydroxyl radicals that are strong 
oxidizing agents. [22] When UV light is used to activate the nanoparticles, 
efficient removal of aromatic organic compounds can be achieved. They 
also provide an absorptive surface for the removal of heavy metals.  Other 
advantages of using TiO2 for water treatment applications are its low cost, 
resistance to corrosion, and overall stability. [3, 4]  
TiO2 nanoparticles have been used as a solid phase extraction 
(SPE) packing material for the remediation of surface waters.  Using TiO2 
nanoparticles as a packing material can effectively preconcentrate and 
extract heavy metals from river water and seawater. [23] This has been 
effectively accomplished in batch and column experiments at the natural 
pH of coastal waters. [24] 
1.3.3 Antimicrobial applications.  Pure TiO2 nanoparticles or TiO2 
nanoparticles doped with other materials such as iron or silver exhibit 
antimicrobial properties.  The nanoparticle composites have been shown 
to be effective at disinfecting airborne bacteria for hospitals and have been 
incorporated into textiles for antimicrobial clothing. [25, 26] The 
photocatalytic antimicrobial activity of TiO2 nanoparticle composites have 
led them to be used in coatings to create self-cleaning surfaces. [27, 28] 
These coatings have found applications in self-cleaning windows and anti-
fogging glass. [8] 
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1.3.4 Health care applications.  TiO2 nanomaterials are being 
evaluated for many different uses in the health care industry.  A platinum 
TiO2 nanocomposite has been shown to be effective in the treatment of 
cancer cells.  [29] TiO2 nanotubes applied to bandages have been shown 
to enhance blood clotting rates by forming a sort of scaffold for blood clots 
to form against. [30] TiO2 nanoparticles have been generated in situ in 
polyurethane membranes to be used as bandages that not only enhance 
clotting, but keep bacteria out while allowing gas permeability and water 
vapor transmission. [31] 
1.3.5 Other novel applications.  TiO2 nanomaterials continue to 
be studied so that they can be utilized in new and exciting ways.  TiO2 
nanomaterials are being evaluated for their capacity for energy storage 
and conversion. [1] TiO2 nanomaterials may also prove to be a low cost 
environmentally friendly means to split water for hydrogen production in 
the future. [32] The potential applications for TiO2 nanomaterials are 
numerous and cover a wide variety of disciplines. 
1.4 TITANIUM DIOXIDE NANOMATERIAL RISK 
 As a bulk material, TiO2 is inert and insoluble which results in a 
relatively high median lethal dose (LD50) for rats of 12,000 mg/kg body 
weight by oral administration. [33] However, TiO2 nanomaterials interact 
with tissues differently than the bulk material making them more toxic.  A 
nanomaterial risk framework must be established to judge the 
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environmental, health, safety risk of any engineering nanomaterial. [34] 
The risk depends on both the hazard potential and external exposure 
likelihood. [10] 
 1.4.1 Risk to human health.  Chronic effects have been observed 
from TiO2 nanoparticle exposure.  Workers in the TiO2 nanoparticle 
production industry in six European countries were more likely to develop 
lung cancer compared to the general population. [35] Though this trend 
was not confirmed in the United States or Canada, there was enough 
concern for the National Institute for Occupational Health and Safety 
(NIOSH) to propose a draft permissible exposure level (PEL) of 1.5 mg/m3 
and a recommended exposure level (REL) of 0.1 mg/m3.  The PEL for 
TIO2 nanoparticles is 15 times lower than the PEL for TiO2 microparticles. 
[9]  
Many exposure and toxicity tests are conducted on rodents rather 
than human subjects.  Two separate studies found that a TiO2 
nanoparticle dose of 5 g/kg body weight did not cause obvious acute 
toxicity in rats. However, there were acute effects on individual tissues in 
the rats. [33, 36] The instillation or inhalation of large doses of TiO2 
nanoparticles have been shown to strongly affect lung function. [37] Other 
localized toxic effects are detailed in Table 1.1. 
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Table 1.1 
Toxic Effects of TiO2 Nanoparticles on Rat Tissues 
Target Organ Effect 
Blood Brain 
Barrier 
Cationic TiO2 nanoparticles can have an immediate 
toxic effect at the blood brain barrier [38] 
Brain Microglia P25 TiO2 can cause sustained production of reactive 
oxygen species [39] 
Central Nervous 
System 
TiO2 nanoparticles can cause increased segmented 
neutrophils and lymphocytes, protein carbonyl levels, 
and interstitial fibrosis [40] 
DNA TiO2 nanoparticles are able to penetrate the nucleus 
membrane and interact with the DNA of cells [40] 
Intestinal Cells TiO2 nanoparticles can cause a rise in intracellular free-
calcium [41] 
Kidney TiO2 nanoparticles caused increased levels of uric acid, 
blood urea nitrogen, and creatine [40] 
Kidney TiO2 nanoparticles can cause swelling of the renal 
glomerulus [33] 
Liver 80 nm TiO2 nanoparticles cause hepatic lesions of the 
liver [33] 
Lung Inflammatory response when TiO2 nanoparticles are not 
recognized by microphages [22] 
Lung TiO2 nanoparticles cause a decreased pulmonary 
diffusion capacity for carbon monoxide [42] 
Lung Chronic TiO2 nanoparticle aerosol exposure leads to an 
increased risk of lung cancer [43] 
Septic Brain TiO2 nanoparticles enhance the inflammatory response 
[44] 
U937 Cells TiO2 nanoparticles resulting from the degradation of Ti 
implants induced cell death by apoptotic and necrotic 
modifications [45] 
Overall Animal studies have given sufficient evidence that TiO2 
nanoparticles are a Group 2B carcinogen [35] 
 
 1.4.2 Ecotoxicology.  The risks to human health come from both 
intentional and unintentional exposure to TiO2 nanomaterials.  Many 
studies have been conducted on intentional exposure such as sunscreen 
application and unintentional exposure such as inhalation of nanoparticles 
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in an improperly controlled production facility.  Less is known about how 
nanomaterials behave once they are released to the environment.  TiO2 
nanomaterials in consumer products like sunscreen are washed off and 
end up in wastewater.  It has been shown that wastewater treatment 
plants (WWTPs) are capable of removing the majority of TiO2 
nanomaterials from influent sewage. [46] However, TiO2 particles 
measuring between 4 and 30 nm were still found in the treated effluent. 
[47] These nanomaterials are then released to the surface waters where 
they can interact with living organisms.  One study monitoring TiO2 
nanomaterials found the highest concentrations in river water to be directly 
downstream of a WWTP. [48] TiO2 nanomaterials that are absorbed in the 
treatment plants may still end up in the environment if the biomass is land 
applied and it later leaches out of the soil.  Though the release of TiO2 
nanomaterials to the environment has been shown, it is difficult to quantify 
how much is released.  Since it is impossible to measure every single 
source of TiO2 nanomaterials, amounts are often modeled to better predict 
how TiO2 nanomaterials may affect the environment. [49] 
 Once in the environment, even less is known about how organisms 
are affected by TiO2 nanomaterials.  Phytotoxicity studies have shown that 
TiO2 nanoparticles inhibited growth of some plants by reducing the 
hydraulic conductivity while others have shown that the particles may 
improve growth by enhancing photosynthesis in leaves and nitrogen fixing 
in roots. [50] It has been shown that fish absorb TiO2 nanoparticles 
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through their gills.  Once into the bloodstream, TiO2 nanoparticles can 
translocate to various organs in the body. [51] Concentrations as low as 
16 mg/L of nanosized TiO2 have been shown to inhibit the growth of algae 
in natural waters. [52] TiO2 has been shown to bioaccumulate, with higher 
concentrations in Daphnia magna at 21 days than at 3 days. [53] 
However, several studies have agreed that TiO2 tends to be a less 
hazardous to organisms than other nanomaterials such as multi-wall 
carbon nanotubes, nano cerium oxide, and nano zinc oxide. [6, 10] 
 The goal of toxicology and ecotoxicology studies is to attempt to 
identify characteristics of the nanomaterials that make them particularly 
toxic.  It had been generally accepted that primary particle size was a 
large factor in assessing toxicity, with smaller particles tending to be more 
toxic.  However, recent studies have shown that particle size is only a 
single (and perhaps minor) factor influencing the toxicity of nanoparticles. 
[34] The reason it is still so difficult to assess the risk of certain 
nanomaterials is that nanotoxicology studies rarely have enough reliable 
information on the physicochemical characteristics of the nanoparticles 
tested. Thus, it is impossible to determine a discernable correlation 
between any single parameter and toxic effect. [52] The results of many 
past nanotoxicology studies have been deemed unreliable because they 
did not adequately characterize the studied nanomaterials.  [37] The 
number of applications for TiO2 nanomaterials continues to grow while 
health and environmental studies attempt to catch up. 
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1.5 MOTIVATION FOR RESEARCH 
 Human exposure to TiO2 nanomaterials is only going to increase as 
the number of applications utilizing TiO2 grows and usage increases.  
Similarly more nanosized TiO2 will ultimately be released to the 
environment.  Large knowledge gaps exist regarding the fate of TiO2 
nanomaterials once they have been used for their designed purpose or 
after unintentional releases.  The goal of this thesis is to develop analytical 
techniques to quantify the level of TiO2 in complex matrices to support 
research of the environmental, health, and safety ramification of TiO2 
nanomaterials. 
1.6 THESIS ORGANIZATION AND OBJECTIVES 
 This thesis is divided into a number of closely related projects all 
pertaining to TiO2 nanomaterials.  Each project is presented here as a 
separate chapter (Chapters 2-7) seeking to complete a specific objective, 
and a chapter synthesizing the findings from all of the projects and 
providing conclusions, recommendations, and future research goals 
(Chapter 8). 
 1.6.1 Objective 1: Create a model for the behavior of TiO2 
nanomaterials absorbed into the body.  One way to better understand 
the fate of TiO2 nanomaterials in the human body is to develop an 
absorption, distribution, metabolism, and excretion (ADME) model.  ADME 
models are often used to better understand the effects of pharmaceuticals 
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on the human body.  The data that are used as inputs to these models 
typically come from rodent studies.  The rodent studies can be used to 
simulate effects of exposure to humans.  These studies will be combined 
in an attempt to create a complete model from the absorption of TiO2 
nanomaterials till their excretion from the body.  Then a hypothetical 
exposure dosage of TiO2 nanomaterials will be added as an input to 
determine distribution though the body and likely concentrations in organs. 
1.6.2 Objective 2: Develop a digestion method to quantify the 
total amount of TiO2 in organic matrices.  In order to verify TiO2 
concentrations in tissues after exposure studies or to find out how much 
TiO2 is contained in consumer products that may release to the 
environment, a digestion method must be developed that can quantify 
TiO2 in various types of samples.  The method must be able to detect 
trace quantities of TiO2 and be capable of efficiently digesting large 
amounts of TiO2, all in a timely manner so that large quantities of samples 
can be analyzed.  The method should also be able to digest any organic 
material that may cause interferences during analysis.   
1.6.3 Objective 3: Measure the total TiO2 content in rat lungs 
instilled with various TiO2 nanomaterials.  Different types of TiO2 
nanomaterials can deposit in the lung and be cleared to different degrees.  
In a collaboration study with the University of California at Davis, rats 
exposed to TiO2 nanomaterials by means of intratracheal instillation were 
analyzed for effects.  The animals were exposed to two crystal structures 
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of TiO2 nanoparticles and TiO2 nanobelts.  Then the animals were 
sacrificed so that the TiO2 could be quantified to measure the TiO2 
concentration per lung mass.  The TiO2 concentration provided information 
about which types of nanomaterials deposit into the lung with a greater 
efficiency and how long it takes for the nanomaterials to clear from the 
lung. 
1.6.4 Objective 4: Measure the total TiO2 in food products and 
separate the nanosized fraction for further analysis.  While many 
products list TiO2 as an ingredient, it is possible that it may be contained in 
other products and remains unlisted.  It was the objective of the project to 
obtain a number of different food products and determine the total TiO2 
content.  Then, to determine the percentage of the total TiO2 content that 
was in the nanoscale size range by filtration.  This was done to know how 
much nanosized TiO2 would have been ingested by a person consuming 
such food products.  TiO2 eventually ends up in wastewater, and the data 
provided a better understanding of how much nanosized TiO2 is released 
into the environment. 
1.6.5 Objective 5: Measure the total TiO2 in personal care 
products and separate the nanosized fraction for further analysis. 
Like food products, it is possible that TiO2 may be contained in personal 
careproducts and remain unlisted.  The objective of the project was to 
obtain a number of different personal care products and determine the 
total TiO2 content.  Then, to determine the percentage of the total TiO2 
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content that was in the nanoscale size range by filtration.  This was done 
to know how much nanosized TiO2 a person would have been exposed to.  
TiO2 eventually ends up in wastewater, and the data provided a better 
understanding of how much nanosized TiO2 may be released into the 
environment. 
1.6.6 Objective 6: Measure the total TiO2 in paint products.  
TiO2 is likely to be found within paints, but how much may vary by brand 
and type.  The objective of this project was to obtain a number of different 
paint products and determine the total TiO2 content.  This was done to 
know how much total TiO2 exists within pain to predict how much might be 
nanosized.  Eventually the paint weathers and TiO2 is released to the 
environment.  Combining these six objectives gave a better idea of how 
much TiO2 a person may be exposed to and how much would be released 
to wastewater and the environment. 
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CHAPTER 2: PHARMACOKINETIC MODELING OF TITANIUM DIOXIDE 
NANOMATERIALS 
2.1 PROBLEM STATEMENT 
Many nanomaterials—TiO2 included—may potentially be 
hazardous, but the direct risk to human health depends on the probability 
of exposure occurring. [1] To better gauge the risk to human health, a 
quantitative risk assessment should be completed.  A quantitative risk 
assessment is defined as “the estimation of the severity and likelihood of 
adverse responses associated with exposure to a hazardous agent” and 
should include a hazard identification, exposure assessment, dose-
response assessment, and risk characterization. [43] One way to 
complete an exposure assessment and dose-response assessment is to 
use a physiologically based pharmacokinetic model.  These types of 
models have been used to study the absorption, distribution, metabolism, 
and excretion (ADME) of pharmaceuticals, but can be applied to 
nanomaterial kinetics in the body with certain modifications to account for 
differences between nanomaterials and pharmaceuticals. [54] It is the 
objective of this project to develop a pharmacokinetic ADME model for 
TiO2 nanomaterials that can predict tissue concentrations based on an 
exposure level. 
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2.2 INTRODUCTION 
 2.2.1 Exposure. An exposure assessment is a critical first step in 
modeling nanomaterial kinetics and characterizing risks to human health.  
Nanomaterial exposure may be intentional or unintentional.  Intentional 
exposure to nanomaterials may result from medical applications such as 
drug delivery or imaging.  Unintentional exposures may come from 
nanomaterials in food, cosmetics, or air and water pollution. [54] While 
pollution, personal care products, and nanomaterials in foodstuffs pose 
some exposure risk to the general population, the population groups most 
susceptible to nanomaterial exposure are those people who work with 
nanomaterials regularly for their careers.  One of these key populations is 
the researchers who study nanomaterials at private labs, universities, and 
in the research and development divisions of private enterprises. [55] A 
study in a research lab found that the airborne concentrations peaked to a 
concentration of 3x103 TiO2 particles/cm
3 within a minute of nanoparticle 
production or use and remained at nearly the same level for 30 minutes. 
[56]  
Another at-risk population is the people who work in the engineered 
nanomaterial production industry.  These workers have a significant risk of 
a cytotoxicity response especially to particles in the size range of 10-30 
nm. [57] The most at-risk workers are those who perform nanomaterial 
handling duties such as bagging, reactor cleaning, bag dumping, pouring, 
and transferring as these duties produce the most dust in the nanosize 
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range. [58] The ventilation schemes near these processes affect the 
nanomaterial concentrations. [55] Concentrations were often measured as 
high as 5.0x105 TiO2 particles/cm
3. [58] For spherical TiO2 nanoparticles 
with an average diameter of 50 nm, this corresponds to a mass 
concentration of 0.14 mg/m3, above the NIOSH REL.  A sudden release of 
TiO2 nanomaterials to the air could raise the concentration much higher.  
One study found the acceptable workplace concentration of TiO2 
nanoparticles to be 1.2 mg/m3 in respirable dust which is close to the 
NIOSH PEL. [22] The producers of P25 TiO2 nanoparticles, Evonik 
DeGussa, claim to keep TiO2 nanoparticle concentrations under 0.5 
mg/m3. [9] These values can be compared to a general background 
particle concentration in a lab which is roughly 0.009 mg/m3. [56] Particle 
levels outside of these production facilities were measured as high as 
1.3x104 particles/m3, 94% of which had diameters <100 nm. [9] While this 
level is higher than ambient levels, it is negligible compared to levels 
inside of the plant, suggesting that the most susceptible population are the 
nanomaterial industry workers.  The only likely high exposure scenario for 
the general public would be if there was an accident where an 
unintentional release of nanomaterials from a plant or during transport 
occurred. [9] 
 In order to reduce exposure to nanomaterials, engineering controls 
and personal protective equipment can be used.  Automated processes, 
fume hoods, and high efficiency particulate air (HEPA) filters can reduce 
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exposure risk.  Respirators and masks may help, but have not been 
proven to effectively remove all nanomaterials. [56, 59] It is also important 
to understand how nanomaterials will behave once airborne.  Particles 
tend to aggregate in the air, shifting the average particle diameter to a 
larger size over time. [58] It was found that the most important mechanism 
driving nanoparticle aggregation is collisions of nanoparticles with other 
nanoparticles and background aerosols. [60] Thus, the most critical risk of 
exposure to smaller sized nanomaterials is to those workers who are near 
nanomaterial dusts when they are first created.   
2.2.2 Toxicity study extrapolation.  Many exposure and toxicity 
tests are conducted on rodents rather than human subjects.  A 
scientifically reasonable approach must be used to extrapolate rodent data 
to humans.  This can be done by allometric relationships between species 
or by lung dosimetry models.  Allometric models are the simpler way and 
are based on the ratios of different metrics between humans and rodents.  
Examples of these factors are tissue weight, tissue surface area, 
respirations rates, and nanomaterial deposition fractions. [22, 43] In the 
absence of other data an equal response is assumed for a normalized 
dose in both species. [43] 
2.3 ABSORPTION 
 Once a subject has been exposed to TiO2 nanomaterials, they must 
be absorbed into the body to have any effect.  Absorption is the process of 
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how a material moves from the external site of exposure to an internal 
biological space. [54] The primary routes for exposure are inhalation, 
ingestion, injection, and absorption by the skin.  The most important 
exposure route is inhalation for two reasons.  One reason is that 
nanomaterial aerosols generally have higher concentrations of 
nanomaterials than anything that would likely be ingested or applied to the 
skin.  Ingestion and dermal exposure are also more likely from intentional 
exposure (i.e. oral drug delivery or sunscreen application), which is better 
understood than unintentional exposure. [61] The second reason is 
because of the large surface area of the lungs and the minimal anatomical 
barriers once nanomaterials reach the alveoli. [62] This chapter focuses 
primarily on inhalation kinetics.  A short review of ingestion and dermal 
exposure is provided along with the reasons that the routes are less 
relevant to exposure than inhalation. 
2.3.1 Gastrointestinal absorption.  Nanomaterials may be 
ingested accidently or intentionally.  These particles can be absorbed by 
the mucosal lining and epithelial barrier in the gastrointestinal associate 
lymphatic tissues (GALT) in as little as 60 minutes. [1] A modeled 
concentration of 10 μg/mL TiO2 nanomaterials in the intestines can cross 
the epithelial lining by transcytosis, but will only result in low 
concentrations after crossing. [41] Positive particles tend to be absorbed 
better, and smaller particles move more easily through barriers. [61] Wang 
[33] showed that TiO2 nanoparticles orally administered to a rat could 
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move from the GALT to the liver, spleen, kidneys, and lung.  However, 
Jani [63] showed that micro-scale TiO2 particles of 500 nm could also 
move to the liver, spleen, and lung with no distribution to the heart or 
kidney. This means that there is little remarkable difference between TiO2 
nanoparticles compared to regular TiO2 particles except that the 
nanoparticles were able to move to the kidney of a rat as well.  Despite the 
translocation of TiO2 nanomaterials from the gastrointestinal tract, no 
negative effects on any rats have been shown as they have been with 
inhalation studies. [61] 
2.3.2 Dermal absorption.  The European NANODERM 3 year 
study of TiO2 nanomaterial based sunscreens used in vitro and in vivo 
techniques to assess whether the particles can penetrate the skin.  The 
results were inconclusive with some studies reporting penetration from the 
surface into deeper epidermal layers and others reporting no penetration.  
The study ultimately concluded TiO2 nanomaterial based sunscreens were 
safe. [64] The skin condition could factor into dermal penetration of TiO2 
nanomaterials.  The nanomaterials may be more likely to penetrate 
deeper into the skin at creases, cracks, or hair follicles as well as more 
readily into damaged skin. [61] One study found penetration was greater 
when applied to hairier skin. [64] There is no clear evidence that TiO2 
nanomaterials that enter the skin are able to enter the systemic circulatory 
system. [40] The reason skin is difficult to penetrate is because of a 10 μm 
thick barrier of strongly keratinized dead cells.  The total area of the skin is 
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roughly 1.6 m2.  This can be compared to the 140 m2 surface area of the 
lungs and the 0.5 μm thick barrier between the airspace in the alveoli and 
the blood flow to illustrate that the lungs are a more likely absorptive site 
for nanomaterials. 
2.3.3 Other absorption sites and exposure routes.  TiO2 
nanomaterials in the body may come from wear and tear of prosthetics in 
the body.  Originally the materials are biocompatible, but at the nano-size 
they can cause inflammatory responses and have been shown to move to 
the liver, kidney, and colon. TiO2 nanomaterials may be transported from a 
mother to a fetus by trans-placenta absorption. [61] Specifically, the TiO2 
nanomaterials were able to affect the brains of the mouse fetuses after 
being administered to their mothers.  This is because the blood-brain 
barrier is not fully developed while in the womb. [65] TiO2 nanomaterials in 
water spray can be inhaled or absorbed through the eye. [9] However, this 
is likely only relevant to those who use concentrated nanomaterial 
solutions in a lab or industrial setting since the highest TiO2 nanomaterial 
concentration directly downstream from paint run-off was only measured 
to be 4 μg/L. [66] Other exposure routes such as intravaginal and 
intravenous exist. [54] However, these exposure routes are less likely and 
less studied than inhalation and pulmonary absorption.  The different 
absorption routes into the body are displayed in Figure 2.1. 
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Figure 2.1 Known and theorized nanomaterial exposure routes. 
2.3.4 Deposition of TiO2 nanoparticles in the lung. Before TiO2 
nanomaterials can be absorbed to the blood from the alveoli, they must 
first be deposited there.  An inhalable dust can enter the respiratory tract, 
but a respirable dust will travel all the way to the alveolar region. [9] TiO2 
nanomaterials are respirable because they will travel to the alveoli.  This is 
important because the epithelial barrier is thinner in the alveolar region.  It 
has been shown that up to 80% of nanomaterials may deposit in the 
lungs.  Particles >100 nm are much less likely to deposit.  [61] One study 
found that 1 nm diameter TiO2 nanoparticles nearly all deposited before 
the alveoli, while one third of 5 nm diameter particles made it to the 
alveoli, and roughly half of 20 nm diameter particles reach the alveoli. [9] 
The deposition rate will also depend on the subject.  Subjects with asthma 
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or pulmonary disease and patients who were exercising had higher 
deposition efficiencies. [42, 67] Deposition rates are covered in more 
detail in Chapter 4.  While deposition fractions might change, Kuempel 
[43] showed that the relationship between external exposure and internal 
dose is linear. 
2.3.5 Pulmonary absorption.  After nanomaterials are deposited 
in the lung, they may absorb from the airspace side into the internal 
biological space.  This is relevant because capillaries carrying blood are 
close to the surface of the alveoli where they exchange gases.  TiO2 
nanomaterials are absorbed to the blood primarily by phagocytosis by 
macrophages or by endocytosis by epithelial and endothelial cells. [40] 
TiO2 nanomaterials exposed to pulmonary macrophages and red blood 
cells are taken up by diffusion or adhesive interactions.  Once within cells, 
they are not membrane bound which greatly enhances their toxic 
potential. [68] It was found that after low concentrations of TiO2 
nanomaterials were absorbed, the epithelial integrity was not disrupted 
when measured by trans-epithelial electrical resistance. [41] However, 
when the epithelial tissue is damaged beforehand, TiO2 nanomaterials can 
absorb into the blood stream more rapidly. [69] TiO2 nanomaterials may 
also absorb into the body by transient passage. [62] This has been shown 
when stimuli caused by the nanomaterials causes the epithelial cells to 
shrink which can create gaps between cells that TiO2 nanomaterials can 
transverse. [70] These mechanisms may work outside of the alveoli in the 
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airways as well.  After rats inhaled a TiO2 nanoparticle aerosol with a 
median diameter of 22 nm, particles were found on the luminal side of 
airways and alveoli, within all major lung tissue compartments and cells, 
and within capillaries. This absorption may occur rapidly.  One study found 
that within 1 hour, 24% of respired TiO2 nanomaterials were found beyond 
the epithelial border.  24 hours later the distribution through the lung 
remained the same. [68] Nanomaterials that are difficult to clear may 
remain in the lung for long periods of time.  This accumulation of 
nanomaterials can provide a persistent source of nanomaterial absorption 
over time. [71] 
 2.3.6 Olfactory nerve absorption.  While most absorption in the 
lungs takes place in the alveoli, the olfactory nerve is another key location 
where absorption can take place.  Nanomaterials can deposit on the 
olfactory mucosa and migrate along the olfactory nerve into the olfactory 
bulb where they are able to interact with the brain. [72] This is important 
because the restrictive brain-blood barrier generally prevents 
nanomaterials from entering the brain.  The olfactory nerve bypasses the 
blood-brain barrier allowing nanomaterial interaction with the central 
nervous system. [61] Larger nanomaterials tend to be better absorbed by 
the olfactory bulb. [40] This is likely because only 10% of 10 nm diameter 
nanomaterials are expected to deposit in the nasopharyngeal region. [73] 
However, micro-sized particles (>100 nm) were unable to be absorbed by 
the olfactory nerve into the brain. [74] 
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2.4 DISTRIBUTION 
2.4.1 Systematic distribution.  The distribution of nanomaterials 
describes how they move through different tissues and through the 
circulatory system to other organs.  Translocation is a term often used to 
describe the combined absorption and distribution of nanomaterials.  Once 
out of the lung, TiO2 nanomaterials may distribute to different systems and 
organs.  One key system is the lymphatic system.  Lymphatic vessels are 
found all through the body except in the cartilage, the eye, and the central 
nervous system.  TiO2 nanomaterials can traverse the body by the 
lymphatic fluid. [54] Uptake of anatase TiO2 nanomaterials increased 
linearly in the lung over time and exponentially in the lymph nodes over 
time. [57] This increase can continue for a long period of time after 
exposure has ended.  A 25 mg/m3 airborne dose of TiO2 nanomaterials 
led to a concentration of nanomaterials in the lymph nodes that continued 
to increase for more than 300 days after the exposure ended. [72] Another 
study confirmed that the lymph node concentration continued to increase 
for 1 year after a 10 mg/m3 dose and peaked at 26 weeks for a 2 mg/m3 
dose. [75] This is caused by the persistence of TiO2 nanomaterials in the 
lung that continue to absorb into the lymph nodes even after exposure has 
ended.  Not only can distribution within the lymph nodes increase  for over 
a half a year, it can also occur very rapidly.  Small nanomaterials (<5 nm) 
moved to the mediastinal lymph nodes with 3 minutes and then on into the 
kidneys within 30 minutes. [62] 
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 Once into the circulatory system TiO2 nanomaterials can reach 
other organs as well.  Small nanomaterials (<5 nm) were not observed in 
the liver or bile, but accumulated in the kidneys and were quickly cleared. 
Larger nanomaterials (27 nm) moved to the lymph nodes in 20 minutes 
and into the blood after 30 minutes.  None of these particles were found in 
the urine, but tended to accumulate in the liver, lungs, and lymph nodes.  
Nanomaterials larger than 34 nm mostly were retained in the lungs. [62] 
This study demonstrates the dependence of distribution on nanomaterial 
diameter.  Another factor is the surface charge of the nanomaterial.  
Positive surface charges tend to be more restrictive for nanomaterial 
distribution. [62] To observe distribution trends, nanomaterials are 
sometimes injected directly into the blood stream. When 2000 μg of 15 nm 
TiO2 nanomaterials were injected into a rat nearly the entire mass 
eventually concentrated in the liver along with 20 μg in the kidney, 10 μg 
in the lungs, and 5 μg in the spleen and blood. [76] A 5 mg/kg body weight 
intravenous dose of 20-30 nm TiO2 nanomaterials led to a 134 μg/g 
concentration in the liver, a 79 μg/g concentration in the spleen, a 8.8 μg/g 
concentration in the lung, and a 0.67 μg/g concentration in the kidney after 
one day.  The concentration of Ti in the liver remained nearly constant 
over 28 days, decreased slightly over 28 days in the spleen, and was 
returned to control levels by 14 days in the lung and kidney. [36] Another 
intravenous study found that 80 nm TiO2 nanomaterials mostly 
accumulated in the liver, while 25 nm TiO2 n nanomaterials accumulated 
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in the spleen, liver, and lungs. [40] A 5g/kg body weight oral dose of 50 
nm TiO2 nanomaterials showed that the majority of the nanomaterials 
went to the liver. [23] No study showed a measurable concentration of 
TiO2 nanomaterials in the brain from pulmonary absorption or intravenous 
exposure. 
2.4.2 Olfactory nerve distribution.  As described previously, 
nanomaterials can bypass the restrictive blood-brain barrier by the 
olfactory nerve.  After exposure to 10 nm diameter TiO2 nanomaterials, the 
particles that deposited remained in the olfactory bulb.  After exposure to 
80 nm diameter TiO2 nanomaterials, the particles were in the olfactory 
bulb within 2 days and inside the brain within 30 days. [33] A dose of 5 
g/kg body weight of 50 nm TiO2 nanomaterials to rats resulted in 100 μg/g 
concentration in the brain, specifically the cortex and hippocampus 
regions.  The same dose of 120 nm TiO2 particles did not result in a Ti 
concentration in the brain significantly different than the control animals. 
[23] The distribution into the brain and the inflammatory response is 
affected by the crystalline structure of the nanomaterial as well.  Anatase 
TiO2 nanoparticles were shown to have a greater inflammatory response 
than rutile TiO2 nanoparticles. [73] The cited studies show that there are 
many different distribution profiles of TiO2 nanomaterials.  While particle 
diameter has a significant effect on distribution; other factors like surface 
charge, surface coating, and crystalline structure have been shown to 
affect distribution as well.  
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2.5 METABOLISM 
Metabolism of nanomaterials broadly means a process within the 
body that will change the nanomaterials’ properties.  Few journal articles 
on nanomaterial metabolism have been published.  Inorganic materials 
are generally stable and hard to metabolize rapidly. [54]  It is difficult for 
the body to metabolize inert nanomaterials; however, organic coatings on 
nanomaterials and metal oxides can be metabolized. [61] It has been 
shown that TiO2 can be dissolved by macrophagic activity in the liver and 
can be considered an easily eliminated compound, unlike asbestos or 
carbon nanotubes. [76] Dissolution is a key factor in the metabolism and 
clearance of nanomaterials.  Though nanomaterials may be more difficult 
to clear for other reasons, they will dissolve faster than micro-sized 
particles.  Even if the dissolution takes weeks or months, it will still 
increase the clearance of nanomaterials. [40] 
2.6 EXCRETION 
2.6.1 Pulmonary Clearance.  Excretion refers the way the body 
eliminates nanomaterials out of the biological space.  In the lungs—as well 
as the gastrointestinal tract—there are competing processes: absorption 
vs. clearance. [54] The lungs are cleared of deposited, unabsorbed 
nanomaterials by two processes.  In the upper region, the mucocilliary 
escalator moves particles upward.  In the alveolar region, nanomaterials 
are cleared by macrophage phagocytosis. [77] Both processes move 
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particles toward the larynx where they enter into the gastrointestinal tract.  
From here they can possibly be found in feces despite no oral 
administration. [78] One study observed that dissolution of TiO2 
nanomaterials was not observed in the lungs and all clearance was 
primarily by the physical and mechanical processes. [79] 
 Transportation of nanomaterials by macrophages can be a slow 
process and may not be able to clear all the particles. [40] One way to 
measure lung clearance is by finding the half-life of particles absorbed into 
the lung.  A 23 mg/m3 dose of 20 nm and 250 nm TiO2 particles was 
administered to rats.  The half-life for the 20 nm TiO2 nanomaterials was 
501 days, while the half-life for the 250 nm TiO2 nanomaterials was only 
174 days. [79] This can be compared to a 6 μm diameter particle which 
would generally be cleared within 1-2 days. [80] Dosage also has a factor 
on clearance rates.  The half-life times were 63 days, 132 days, and 395 
days for doses of 0.5 mg/L, 2 mg/L, and 10 mg/L TiO2 nanomaterials 
respectively.  This prolongation of particle clearance for higher doses is 
indicative of pulmonary overload. [75] If a particle larger than 200 nm 
reaches the lower regions of the lungs, it is generally responded to by 
macrophages within a few hours.  However, smaller nanomaterials are 
often “hidden” from the macrophages for long periods of time that increase 
the clearance time. [80] 
2.6.2 Systematic Clearance.  Once into the circulatory system, 
excretion mainly occurs by the liver and kidneys, with small nanomaterials 
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(<5.5 nm) being almost completely cleared by the kidneys into the urine. 
[54, 62] Intravenously introduced TiO2 nanomaterials cleared from the 
kidney, blood, and spleen within 72 hours.  One month later 30% of the 
peak concentration of nanomaterials had cleared from the liver into the 
bile. [76] The clearance times for the circulatory systems are generally 
much faster than the lungs if there is not a persistent source remaining in 
the lungs.  Other excretion routes such as by sweat or breast milk have 
been theorized, but not yet proven. [54, 61] 
2.6.3 Accumulation.  If nanomaterials are unable to clear, they 
may accumulate in the organs.  The retained dose is a result of 
biopersistence of a compound and is a function of deposition rates and 
clearance rates. [79] Lipid soluble nanomaterials may deposit in the lung 
surfactant where they can be retained for months or even years. [59] 
These lipid soluble nanomaterials may also be retained in the intestinal 
fluid unless they are biodegraded or cleared by chemical dissolution. [40] 
High accumulation is likely to occur where nanomaterials are 
administered, especially the lungs and the gastrointestinal tract.  There is 
virtually no accumulation in the brain and low accumulation in the kidneys 
and muscles.  However, because the muscles are larger than the kidneys, 
they may have a high absolute mass despite a low concentration. [54] By 
accumulation processes, one can see how if nanomaterials are not 
cleared, they can build up over long periods of time and cause chronic 
health problems. 
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2.7 MODEL DEVELOPMENT 
 The data gathered from TiO2 nanomaterial ADME studies 
mentioned above were combined to create a model capable of modeling 
how two different sized of nanoparticles will move throughout the body 
based on different exposure types and exposure levels.  The ADME model 
was created from inhalation, ingestion, and injection studies that recorded 
the concentrations of TiO2 nanomaterials in different tissues after the 
animals were sacrificed.  The organs that were consistently studied were 
the lymph nodes, liver, kidneys, spleen, and brain. [23, 33, 36, 73, 79] The 
model dose was scaled linearly to the dose used in the studies in order to 
predict the tissue concentrations.  When available, the model is based 
upon different times post dosage.  The inputs and calculations used for 
the model can be seen in Figure  
2.7.1 Hypothetical exposure scenarios.  To better illustrate the 
effect particles size has on the pharmacokinetics of TiO2 nanomaterials, 
two hypothetical exposure scenarios were created.  The duration, airborne 
concentration, and size of the TiO2 nanomaterials were varied to simulate 
possible workplace environments.  The two exposure scenarios are shown 
in Table 2.1.  The first scenario is a moderate nanoparticle concentration 
of 5 nm diameter particles for a 4 week period of 8 hour work days.  The 
second scenario is a high nanoparticle concentration of 25 nm diameter 
particles for just 3 work days.  The final concentrations in the tissues 
resulting from inhalation are shown in Tables 2.2 and 2.3.  A similar 
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dosage (mass per body weight) of 25 nm diameter TiO2 nanoparticles was 
modeled as being ingested and injected.  The results are shown in Table 
2.4. 
Table 2.1 
Hypothetical Exposure Scenarios 
Hypothetical Exposure Dose # 1 Dose # 2 
Nanoparticle Level Moderate High 
Airborne 
Concentration 2 mg/m3 2.5 mg/m3 
Nanoparticle Diameter 5 nm 25 nm 
Worker Status Healthy Healthy 
Exposure Length 4 weeks 3 days 
Subject Weight 70 kg 70 kg 
Blood Volume 5 L 5 L 
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Figure 2.2 ADME Inhalation Model Flowchart: Ovals indicate inputs, green boxes indicate outputs, black 
lines are TiO2 moving through the body, and the line thickness indicates relative TiO2 mass.
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Table 2.2 
Modeled Inhalation Tissue Concentrations: Hypothetical Dose #1 
INHALATION 
Input Value Unit 
Mass Deposited in Alveoli 128 mg 
Inhalation Dose 1.8 mg/kg 
Mass Absorbed to Blood (10 min) 35.8 mg 
Mass Absorbed to Blood (30 min) 64 mg 
Maximum Blood Concentration 12.8 ug/mL 
Lymph Node Concentration (10 min) 0.7 mg/g 
Lymph Node Concentration (30 min) 1.3 mg/g 
Mass Cleared by Urine 9.3 mg 
Maximum Kidney Concentration 66.3 ug/g 
Brain Concentration Negligible ug/g 
Liver Concentration Negligible ug/g 
Spleen Concentration Negligible ug/g 
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Table 2.3 
Modeled Inhalation Tissue Concentrations: Hypothetical Dose #2 
INHALATION 
Input Value Unit 
Particle Mass Inhaled 72 mg 
Mass Deposited in Alveoli 36 mg 
Inhalation Dose 0.5 mg/kg 
Mass Absorbed to Blood 8.6 mg 
Maximum Blood Concentration 17.3 ug/mL 
Mass in Lymphatic System (100 days) 1.1 mg 
Kidney Concentration (1 day) 0.02 ug/g 
Kidney Concentration (14 days) 0.005 ug/g 
Kidney Concentration (28 days) 0.005 ug/g 
Liver Concentration (1 day) 3.3 ug/g 
Liver Concentration (14 days) 2.5 ug/g 
Liver Concentration (28 days) 2.8 ug/g 
Spleen Concentration (1 day) 1.9 ug/g 
Spleen Concentration (14 days) 1.1 ug/g 
Spleen Concentration (28 days) 0.8 ug/g 
Brain Concentration (1 day) 1.2 ng/g 
Days Post Exposure 501 days 
Mass Remaining in Lungs 18 mg 
 
  
35 
 
Table 2.4 
Modeled Ingestion and Injection Tissue Concentrations: Hypothetical 
Dose #2 
  INGESTION INJECTION 
Input Value Unit Value Unit 
Ingestion Dose 5.0 mg/kg 5.0 mg/kg 
Mass Absorbed to Blood 2.8 mg 350 Mg 
Maximum Blood Concentration 0.6 ug/mL 70 ug/mL 
Kidney Concentration (1 day) -   0.67 ug/g 
Kidney Concentration (14 days) 0.375 ng/g 0.20 ug/g 
Kidney Concentration (28 days) -   0.20 ug/g 
Liver Concentration (1 day) -   134 ug/g 
Liver Concentration (14 days) 0.107 ng/g 99 ug/g 
Liver Concentration (28 days) -   111 ug/g 
Spleen Concentration (1 day) -   79 ug/g 
Spleen Concentration (14 days) 0.580 ng/g 49 ug/g 
Spleen Concentration (28 days) -   33 ug/g 
Brain Concentration (1 day) 0.15 ng/g 0.10 ng/g 
 
2.7.2 Clearance rates.  It is important to understand how TiO2 
nanomaterials remaining in the lung can act as a persistent source of 
absorption into the body.  Small nanoparticles can have an especially long 
half-life in the lung before they are cleared.  The clearance of TiO2 
nanomaterials can decrease linearly or decay exponentially depending on 
the initial dosage.  The mass deposited decrease from the lungs, modeled 
as an exponential decay for each of the two exposure scenarios can be 
seen in Figure 2.2 and Figure 2.3 which show the clearance of TiO2 
nanoparticles over time. 
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Figure 2.3 TiO2 nanoparticle lung clearance for exposure scenario #1 
 
Figure 2.4 TiO2 nanoparticle lung clearance for exposure scenario #2 
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2.8 DISCUSSION 
 TiO2 nanomaterials are already used in applications in many 
different industries, and their use increases every year.  The most 
susceptible people are those who regularly are exposed to TiO2 
nanomaterials in their workplace.  To judge how TiO2 nanomaterials are 
taken up and distributed by the body, pharmacokinetic ADME models can 
be applied.  The most important absorption route in the body is pulmonary 
absorption.  The importance of pulmonary absorption is reflected by the 
TiO2 nanomaterial tissue concentrations from inhalation being 4 orderes of 
magnitude higher than the tissue concentrations from ingestion.  Though 
ingested and dermally applied nanomaterials are not as relevant from a 
human health standpoint, there are still environmentally relevant as a 
waste after being excreted or washed off. 
From the lungs TiO2 nanomaterials can be distributed to the 
lymphatic system, brain, liver, kidney, and spleen.  The distribution 
throughout the body depends largely on nanomaterial diameter, but also 
on other factors like surface charge as well.  TiO2 nanomaterials may be 
metabolized in the liver, primarily by dissolution by the macrophages.  The 
nanomaterials are cleared from the lungs by the mucocilliary escalator and 
phagocytosis by macrophages.  They are cleared from the circulatory 
system primarily by the liver and kidneys depending on particle size.  TiO2 
nanomaterials will primarily end up in feces if ingested or cleared from the 
lungs to the esophagus.  Those nanomaterials cleared by the kidneys will 
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end up in urine.  If particles are not excreted they can accumulate in 
organs and remain there for months or years.  Studies of TiO2 toxicity and 
ADME are complicated by the many factors that must be accounted for 
when studying nanomaterials.  This chapter has demonstrated some of 
the kinetic behaviors of TiO2 nanomaterials in the body, but it is important 
to remember many knowledge gaps still exist and the risk to human health 
created by TiO2 nanomaterials warrants further study. 
2.9 SUMMARY 
 Inhalation is the most important exposure route for human health 
implications of TiO2 nanomaterials. 
 TiO2 nanomaterials are more slowly cleared from the lungs than 
larger particles and have greater toxic effects with the half-life being 
as high as 501 days. 
 TiO2 nanomaterials may distribute to the lymphatic system, brain, 
kidneys, liver, and spleen.  Modeled liver concentrations were 
generally highest, as much as 3.3 μg/g after inhalation. 
 Primary particle size plays an important role in the ADME of 
particles as dose crystal structure, surface coating, and charge. 
 Extremely small TiO2 nanomaterials (< 5nm diameter) are excreted 
by the kidneys through the urine. 
 Larger TiO2 nanomaterials (~25 nm) are more likely to be excreted 
in bile from the liver.  
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CHAPTER 3: TITANIUM DIOXIDE QUANTIFICATION METHOD 
DEVELOPMENT 
3.1 INTRODUCTION 
 Spectrometric methods can be used to determine trace metals, 
including Ti from TiO2 bulk and nanomaterials, in environmentally and 
biologically relevant matrices.  Two popular methods are inductively 
coupled plasma mass spectrometry (ICP-MS) and inductively coupled 
plasma optical emission spectrometry (ICP-OES). In both methods, the 
sample is nebulized and a small part of the sample enters a plasma torch 
where it is atomized and conveyed to a spectrometer.  ICP-MS 
instruments use the mass to charge ratio of the ions to differentiate 
species, ICP-OES instruments use the different optical emissions of 
elements to differentiate.  The two spectrometric methods have become 
popular because they allow for multi-elemental analysis of both major and 
trace elements and are capable of rapidly processing a large number of 
samples requiring only a minimal sample volume. [81, 82] ICP-MS and 
ICP-OES methods have been shown to be more accurate than 
photometrical methods. [83] 
 A key sample preparation step for inductively couple plasma 
spectrometry is the conversion of solid samples to a representative 
solution so that the entirety of the element in question is atomized in the 
plasma. [84] Direct injection of unprepared samples into the spectrometer 
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has proven inefficient because samples may have a high viscosity or be 
insoluble. [85] Matrix constituents such as a high concentration of 
suspended solids can suppress the torch plasma which can also cause 
incomplete atomization and ionization of the elements. [84] A digestion 
procedure can be used “to reduce interferences by organic matter and 
convert metals associated with particulate matter to a form…that can be 
determined by inductively coupled plasma spectrometry.” [86] 
 A number of different methods have been devised to adequately 
digest samples before an inductively coupled plasma spectrometry 
analysis.  Digestion procedures generally involve adding acids and/or a 
catalyst to a sample.  Different combinations and proportions of nitric acid, 
hydrochloric acid, sulfuric acid, perchloric acid, phosphoric acid, 
hydrofluoric acid, and hydrogen peroxide have all been evaluated for the 
digestion of organic and inorganic metals containing trace metals including 
Ti. [81, 82, 84-90] Standard Methods recommends that if possible, it is 
ideal to use only very pure nitric acid to prevent spectrometric 
interferences; but the digestion of TiO2 requires a stronger digestion 
method. [86] It has been shown that either a mix of hydrogen peroxide, 
nitric acid, and sulfuric acid or hydrogen peroxide, nitric acid, and 
hydrofluoric acid can sufficiently digest TiO2.  [81, 87, 89] Using reference 
standards, the recovery of Ti after digestion has been shown to be 95 
percent or greater. [84, 85, 87, 88, 90] The spectrometry results were 
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further verified by X-ray fluorescence and spectrophotometric methods. 
[84, 90] 
 Microwaves and hot plates are two common standard methods 
used to heat samples after acids are added in order to accelerate the 
digestion.  Heating temperature and heating time have both been shown 
to have large effects on digestion efficiency. [88, 91] Ashing has been 
used for the digestion of samples; however, studies have shown that 
ashing before digestion had little effect on the digestion efficiency of TiO2 
and can cause losses. [88] 
 For Ti analysis both ICP-MS and ICP-OES have been shown to be 
sufficient for a variety of sample types. [89, 92] The ICP-MS generally has 
a lower instrument detection limit (IDL) and is used for ultra trace metals 
analysis. [86, 93] No other technique can currently approach the sensitivity 
of an ICP-MS instrument for multielemental analysis.  The power of ICP-
MS is reflected in the fact that the use of ICP-MS continues to grow while 
the use of ICP-OES has reached a steady state. [94] ICP-MS also has the 
ability to determine isotope fractionation of elements. [89] However, an 
ICP-MS instrument is more expensive to purchase and more complex to 
operate and maintain than an ICP-OES instrument. [92] ICP-OES 
instruments can handle a higher amount of total dissolved solids in each 
sample as well requiring less sample preparation than samples analyzed 
by an ICP-MS instrument.  Thus, there is a tradeoff between ease of use 
and capability in the instruments. 
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3.2 PROBLEM STATEMENT 
 The objective of this project was to develop a quantification method 
consisting of a digestion procedure and analysis procedure capable of 
accurately measuring TiO2 at widely varying concentrations.  The 
digestion procedure had to be capable of digesting large numbers of 
samples using the resources available at Arizona State University.  The 
digestion method had to efficiently digest all Ti so that complete ionization 
of the Ti can occur in the plasma.  The digestion method had to digest any 
organics or solids that could cause interferences during analysis or 
damage to the instruments.  The analysis procedure had to optimize the 
use of the inductively coupled plasma spectrometry instruments available 
at Arizona State University.  An IDL was established for each ICP 
instrument to determine which can quantify titanium at lower 
concentrations.  Then a method detection limit (MDL) was established for 
the digestion and analysis. 
3.3 MATERIALS AND METHODOLOGY 
3.3.1 Choice of digestion reagents.  As described in the 
introduction, there are various acid combinations that can be used to 
adequately digest TiO2 for analysis.  One proven digestion method uses a 
combination of nitric and sulfuric acid to digest the TiO2.  While this 
method may provide a good recovery of Ti, it was not optimal for ICP-MS 
analysis because the sulfur oxide species (S-O) has a mass to charge 
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ratio (m/z) of 48 which interferes with the primary Ti isotope which is also 
48.  Using sulfuric acid as a digestion reagent would have made 
quantification of trace concentrations of Ti impossible by ICP-MS.  ICP-
OES could still be used, but the detection limit of ICP-OES was not 
thought to be as low as ICP-MS.  Another popular method used by 
geologists is a combination of nitric acid, hydrochloric acid, and 
hydrofluoric acid.  However, the chlorides from the hydrochloric acid can 
complex with elements in the water that may be analyzed during 
environmental monitoring.  These complexes can cause precipitation of 
solids in the solution or cause interferences for analysis. 
 Packer et al. found that a combination of nitric acid, hydrogen 
peroxide, and hydrofluoric acid was able to digest Ti in ceramic materials. 
[89]  Nitric acid, hydrogen peroxide, and hydrofluoric acid were chosen to 
be evaluated as reagents for the digestion of TiO2.  The reagents were all 
Ultrapure acids purchased from JT Baker.  The percentage acid and Ti 
levels for the reagents are shown in table A.1. It should be mentioned that 
hydrofluoric acid is extremely hazardous. [95] However, with caution and 
the use of proper personal protection equipment (PPE) and an adequate 
fume hood, the hazard of using hydrofluoric acid can be minimized. 
3.3.2 Digestion procedure.  Two digestion procedures were 
evaluated, a hot plate digestion method and a microwave digestion 
method.  In the hot plate method, sample was added to a 150 mL 
polytetrafluoroethylene (PTFE or Teflon) beaker along with 10 mL of 
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hydrogen peroxide and 2 mL of nitric acid.  The beakers were heated at 
120° C for 4 hours to digest the organics.  The beakers were removed 
from the hot plate and allowed to cool.  Then 8 mL of nitric acid and 2 mL 
of hydrofluoric acid was added.  The beakers were heated on a hot plate 
at 120° C to digest the TiO2 and evaporate the acids. When 0.1 to 0.5 mL 
of solution remained, the beakers were removed from the hot plate and 
allowed to cool.  Then the beakers were rinsed >3 times with a solution of 
2% nitric acid in nanopure (resistivity = 18.3 MΩ*cm) water into a 25 mL 
volumetric flask before being stored for analysis. 
 In the microwave digestion method, sample was added to a 55 mL 
microwave digestion vessel along with 8 mL of nitric acid and 2 mL of 
hydrofluoric acid.  The vessels were digested using a Microwave Assisted 
Reaction System (MARS) Express instrument.  The microwave digestion 
program can be seen in Table 3.1.  After cooling, the sample was rinsed 
>3 times using approximately 20 mL of a 2% nitric acid solution into a 
Teflon beaker.  2 mL of hydrogen peroxide was added to each beaker to 
digest any remaining organics.  The beaker was then heated on a hot 
plate at 180°C until between 0.1 and 0.5 mL of solution remained.  The 
beakers were removed from the hot plate and allowed to cool.  The 
beakers were rinsed >3 times with a 2% nitric acid solution into a 25 mL 
volumetric flask before being stored for analysis. 
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Table 3.1 
MARS Express Microwave Digestion Parameters 
Power Ramp Time Temperature Hold Time 
1200 W 15:00 150°C 0:00 
1200 W 15:00 180°C 20:00 
 
 In both digestion procedure, the solution was evaporated and 
diluted to ensure that the maximum concentration of HF in the final sample 
was 2%.  The actual concentration is likely much lower because the HF is 
more likely to evaporate upon heating than HNO3.  This was done to 
ensure that there is no etching of the glassware on the spectrometers from 
the hydrofluoric acid.   
The digestions were evaluated for the recovery of a known amount 
of TiO2 and ability to digest organics sufficiently for analysis.  A solution 
with a known amount of TiO2 was digested to evaluate the Ti recovery 
efficiency.  A piece of tripe was digested with the TiO2 solution to simulate 
an organic sample.  Tripe was chosen because it is an exceptionally tough 
tissue and a method that could digest tripe should be robust enough for 
any tissue sample.  The digestion method was applied to a number of 
method blank samples, containing only the reagents and no sample, in 
order to measure the amount of Ti contamination that is likely to occur.  
The data was used to find the digestion MDL after the IDLs were 
established for each instrument.  Whole milk was used to evaluate the 
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ability of the digestion procedure to digest samples with a high organic 
content. 
3.3.3 TiO2 stock preparation.  The digestion methods were 
evaluated using a TiO2 nanoparticle solution.  The nanoparticles used 
were P25 TiO2 purchased from the Evonik DeGussa Corporation that 
consist of a 81%/19% anatase/rutile TiO2 crystal structure mix with an 
average primary particles size of 24 nm. [96] A stock solution was 
prepared by adding the desired weight of P25 to nanopure water and 
sonicating for 30 minutes in a Bronson 2510 bath sonicator at a 40 kHz 
frequency.  A serial dilution of the stock was done to create various 
concentrations for the digestion evaluation. 
3.3.4 ICP analysis.  Analysis was conducted by ICP-OES and ICP-
MS to compare the two instruments.  Ti standards were prepared in 2% 
nitric acid to match the matrix of the samples.  The concentrations for the 
Ti standards were chosen in the range where the concentration and CPS 
are related linearly to create a linear calibration curve.  Samples with 
concentrations above the highest standard concentration were diluted so 
that they fell within the calibration curve.  Quality control blank checks and 
external calibration verification checks were run regularly throughout the 
analysis.  An internal standard was used to account for fluctuations in the 
plasma temperature.  Scandium was used as the internal standard 
because it has an ionization energy close to Ti.  Instrument detection limits 
were determined according to the method prescribed by the 
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Environmental Protection Agency in the Code of Federal Regulations 
(CFR) Title 40: Part 136 Appendix B. [97] The instrument with the lower 
detection limit for Ti was further optimized for sensitivity and repeatability. 
 The ICP-MS instrument evaluated was a Thermo X Series 2 
quadrupole.  The instrument was equipped with a standard quartz torch 
assembly, a concentric nebulizer, a double-pass spray chamber, and a 
CETAC ASX-520 autosampler.  The instrument was tuned with a solution 
containing lithium, indium and uranium at a concentration of 10 μg/L.  A 
2% nitric acid solution was used as a rinse between all samples.  The 
operating parameters for the ICP-MS instrument are shown in Table 3.2.  
A performance report was conducted on the instrument to evaluate the 
sensitivity and stability of the signal.  The requirements for a passing 
performance report are shown in Appendix A Table A.2.  Ti isotope mass 
to charge ratios of 46, 47, 48, 49, and 50 were all evaluated.  The typical 
detection limit provided by the manufacturer listed Ti minimum detection 
as 0.01 μg/L.   
 The ICP-OES instrument evaluated was a Thermo iCAP 6200 ICP 
Spectrometer.  The instrument was equipped with a standard quartz torch 
assembly, a concentric nebulizer, a cyclonic spray chamber, and a 
CETAC ASX-520 autosampler.  A 2% nitric acid solution was used as a 
rinse between all samples.  The operating parameters for the ICP-OES 
are shown in Table 3.2.  The wavelengths of 3234 Å and 3349 Å were 
both monitored for optical emissions due to the presence of Ti.  The 
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typical detection limits provided by the manufacturer listed Ti minimum 
detection as 0.01 to 0.1 μg/L.   
Table 3.2 
Operating Condition for the ICP-MS and ICP-OES Instruments 
 ICP-MS ICP-OES 
Instrument Thermo X-Series 2 Thermo iCAP 6200 
RF Power 1350 W 1150 W 
Nebulizer Flow 0.87 L/min 1 L/min 
Auxiliary Flow 0.7 L/min 0.5 L/min 
Sample Flow 0.4 mL/min 2 mL/min 
Equilibration Time 1.5 ms - 
Background Correction 450 CPS 220 CPS 
Measurement Process Peak Height Peak Height 
Integration Time 3 s 5 s 
Uptake Delay 60 60 
Rinse Delay 30 30 
Number of Replicates 3 3 
 
3.3.5 Cleaning.  Between digestions, all glassware, Teflon, and 
microwave digestion vials were filled with a 10% nitric acid solution and 
sonicated for 10 minutes.  The labware was then rinsed 3 times with 
nanopure water and dried.  Cones in the ICP-MS and ICP-OES 
instruments were cleaned regularly.  Sample tubes for the autosampler 
were disposable and only used for one sample.   
3.4 RESULTS 
 3.4.1 Digestion of organics.  5 mL of whole milk was digested by 
the microwave digestion and hot plate digestion methods.  The microwave 
digestion method produced a clear sample.  The hot plate digestion 
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method produced a dark sample that still had visible solids.  The samples 
are shown in Figure 3.1.  Running the hot plate digestion samples through 
the ICP-MS and ICP-OES instruments caused the sensitivity on both 
instruments to decrease so much that both instruments required extensive 
maintenance.  All sample tubing had to be replaced.  Running the 
microwave digestion samples through the ICP-MS and ICP-OES 
instruments had no effect on the sensitivity.  This was verified by running 
another performance report after analysis of the digestion samples.  The 
performance report passed. 
 
Figure 3.1. Whole milk digested by hot plate digestion (right), microwave 
digestion (center), and microwave digestion with hydrogen peroxide (left).  
All samples shown were blanks, with no TiO2 added. 
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 3.4.2 Digestion of TiO2.  10 mL of a 1 mg/L P25 TiO2 nanoparticle 
solution was digested in triplicate with a piece of tripe by the microwave 
digestion and hot plate digestion methods.  Both methods produced a 
clear sample that had no effect on the spectrometers.  The microwave 
digestion had a recovery of 95.3 +/- 6.5%.  The hot plate digestion had a 
recovery of 94.2 +/- 13.5 %.  Because the microwave digestion method 
gave a good recovery and slightly more consistent results, the method 
was evaluated for higher concentrations of TiO2 to ensure that the method 
was robust enough to digest larger quantities of Ti.  10 mL of both a 10 
mg/L and a 100 mg/L P25 TiO2 nanoparticle solution were digested in 
triplicate with a piece of tripe by the microwave digestion method.  The 
results are shown in Table 3.3. 
Table 3.3 
Microwave Digestion Ti Recovery 
Sample Concentration Recovery (%) % Std. Dev. (n=3) 
1 ppm 95.3 6.5 
10 ppm 99.2 14.8 
100 ppm 86.3 0.7 
 
 3.4.3 Instrument method detection limit.  The IDL was 
determined for the ICP-MS and ICP-OES instruments.  A 2 μg/L Ti 
standard and a 5 μg/L Ti standard were prepared.  Each standard was 
analyzed 10 times on both of the instruments.  The IDL was then 
calculated for each instrument by the EPA method using equation: 
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MDL = σ (n) * t (n-1, 0.01) 
Where σ (n) is the standard deviation of the replicates, and t (n-1, 0.01) is 
a value from a t distribution based on the number of replicates.  The IDLs 
are shown in Table 3.4.  To further verify the sensitivity of each 
instrument, a calibration curve was created for each instrument using low 
concentrations of Ti (less than 10 μg/L).  A linear trend line was added to 
each calibration to compare the R2 values for each instrument.  The 
calibration curves are shown in Figure 3.2 and Figure 3.3.  The R2 value 
for the ICP-MS instrument was 0.996 using the Ti isotope 49, the R2 value 
for the ICP-OES instrument was 0.966 for the Ti emission wavelength 
3234 Å.  Other isotopes and wavelengths were evaluated as well.  The 
ICP-MS calibration curve for 49 is shown because it had less 
interferences, the ICP-OES calibration curve is shown for 3234 Å is shown 
because it had the highest relative intensity of any Ti emission 
wavelength. 
Table 3.4 
Instrument Method Detection Limit 
Test Concentration ICP-MS (Ti 49) ICP-OES (Ti 3234) 
Stated MDL 10 ng/L   10-100 ng/L 
2000 ng/L 81 ng/L 562 ng/L 
5000 ng/L 164 ng/L 491 ng/L 
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Figure 3.2.  ICP-MS calibration curve 
 
Figure 3.3 ICP-OES calibration curve. 
 3.4.4 Digestion method detection limit.  Twelve method blanks 
were digested using the microwave digestion method and analyzed by 
ICP-MS.  The results are shown in Figure 3.4.  The blanks were digested 
and evaporated at different times over the course of 3 weeks.  The 
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average amount of Ti for the 12 blanks was 496 ng with a maximum of 
2.07 μg.  Generally the samples had less than 500 ng of Ti after the 
complete digestion method.  Only method blank #10 had over 2 μg of Ti 
which was over 3 times higher than the closest method blank.  It was 
determined that the Teflon beaker had been improperly washed and blank 
#10 was considered to be an outlier.  If method blank #10 is considered an 
outlier and ignored, the average for the remaining 11 blanks is 353 ng Ti 
with a maximum of 593 ng.  Thus, any sample measuring below an 
absolute Ti mass of 600 ng would be considered to be below the digestion 
MDL.  This corresponds to a TiO2 MDL of 1 μg. 
 
Figure 3.4. Digestion method detection limit of microwave digestion 
blanks. 
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3.5 DISCUSSION 
 3.5.1 Digestion method evaluation.  The microwave digestion 
method proved to be a better method than the hot plate digestion method.  
The hot plate digestion method was totally incapable of handling high 
organic contents as proven by the milk digestion results.  The microwave 
digestion method broke down the tissue and milk in the samples very well.  
After evaporation, if any color remained hydrogen peroxide was added 
and the sample was heated again.  It is important that the samples be as 
free of organics and solids as possible to minimize the required 
maintenance time on the instrument.  During an analysis using the ICP-
MS instrument, as many as 150 microwave digested samples were run at 
one time and a performance report conducted after the sample set was 
finished indicated that the sensitivity of the instrument had not decreased 
at all. 
 The TiO2 recovery for both methods was greater than 90%.  When 
digesting higher concentrations of TiO2 by the microwave digestion 
method, the recovery was still high and there was less than a 15% 
standard deviation in the triplicate samples.  The recovery was not 
perfectly 100%, but any impurities in the TiO2 P25 stock powder or 
heterogeneity of the nanoparticle solutions would cause the recovery to be 
less than 100%.  However, the recoveries were generally in good 
agreement with those found in the literature. 
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For ultra-trace samples, the amount of Ti contamination was kept to 
a minimum by following proper cleaning procedures.  The Ti concentration 
that corresponds to the digestion MDL was 24 μg/L which is well above 
the IDL for either instrument.  The contamination likely occurred during the 
evaporation of the acids in the Teflon beakers.  The samples may remain 
uncovered for up to 4 hours while the acids evaporated.  During this time, 
Ti particles in the air may deposit in the sample.  Each batch of rinse water 
used was analyzed and the Ti concentration was always near zero.  For 
samples with Ti concentrations near the digestion MDL, increasing the 
total amount of sample digested or spiking in a known amount of Ti could 
provide more reliable data. 
 3.5.2 Instrument optimization.  The ICP-MS IDL was significantly 
lower than the ICP-OES instrument.  The better sensitivity of the ICP-MS 
instrument is reflected in the calibration curve.  The linear trend line for the 
ICP-MS had a higher R2 fit value than the ICP-OES instrument.  When 
looking at how many counts per second (CPS) the instrument recorded, 
the 1 μg/L standard had a CPS value that was three time higher than the 
blank standard.  For the ICP-OES instrument, the 1 μg/L standard only 
had a CPS value that was roughly 15% higher than the blank standard.  
The larger increase of CPS values in comparison to the background 
further demonstrates the sensitivity of the ICP-MS instrument. 
 The ICP-MS instrument had multiple Ti mass lines that could be 
monitored.  The ICP-OES instrument had multiple Ti emission lines that 
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could be monitored.  For the ICP-OES instrument, Ti emission wavelength 
3234 Å had a higher relative intensity than wavelength 3349 Å and better 
sensitivity at low concentrations.  For the ICP-MS instrument, Ti 48 m/z 
was the most abundant isotope.  However, due to interferences from 
sulfur oxide and phosphorus oxide species that occur in organic samples, 
an accurate quantification of Ti could not be achieved.  Similar 
interferences occurred with the Ti 47 m/z isotope.  These interferences 
can be seen in Figure 3.5.  When analyzing the complete mass spectrum, 
phosphorus can clearly be detected as shown by Figure 3.6.  No 
quantification of the Ti 46 m/z isotope could be determined due to high 
interferences from the scandium 45 m/z isotope.  For the two remaining 
mass isotopes, Ti 49 m/z and Ti 50 m/z, the Ti 49 m/z isotope was more 
abundant.  Ti 49 m/z on the ICP-MS instrument was designated as the 
best option for analysis because of the lower instrument detection limit 
and lack of interferences despite the lower responses resulting in higher 
MDLs. 
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Figure 3.5.  Mass spectra for two samples with similar amounts of Ti.  One 
sample (above) had no organic content, while the second sample (below) 
had digested rat lung tissue which contained phosphorus. 
58 
 
 
Figure 3.6.  Phosphorus comparison between a digested rat lung sample 
with organics and a sample without organic material. 
3.6 SUMMARY 
 The digestion method degraded organic material enough that the 
samples could be analyzed by ICP without damaging the 
instruments. 
 The digestion method had greater than 86% recovery of Ti. 
 ICP-MS was the best choice for quantifying Ti because the 
detection limit of 164 ng/L was lower than ICP-OES detection limit. 
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 Ti isotope 49 m/z is the best isotope to monitor because it has the 
least interferences from other species like P-O and S-O complexes. 
 The MDL for the digestion method was 1 μg TiO2. 
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CHAPTER 4: TITANIUM DIOXIDE NANOMATERIAL MORPHOLOGY 
EFFECT ON DEPOSITION AND CLEARANCE IN RAT LUNGS 
4.1 INTRODUCTION 
 4.1.1 Pulmonary deposition of TiO2 nanomaterials.  A review of 
literature regarding the deposition rates of TiO2 nanomaterials stated that 
nanoparticles between 20-40 nm in diameter may deposit in the alveoli 
with 30-60% efficiency.[9, 61]  Nanomaterials deposit by different 
mechanisms than larger particles because of their small size.  
Nanomaterials tend to deposit due to diffusion rather than inertial 
impaction, gravitational sedimentation, or interception like larger particles. 
[80] In terms of total mass, one rat inhalation study has shown that a 0.11 
mg/m3 TiO2 aerosol containing 22 nm agglomerates resulted in a 
deposition of 4-5 μg per rat in just one hour of exposure.  [68] It is 
important to distinguish between primary particle size and agglomerate 
size in the aerosol.  One study generated an aerosol from 20-30 nm 
primary sized TiO2 nanomaterials, but found that only a 0.5% mass 
fraction of the agglomerates had a diameter measuring less than 100 nm.  
As a result only 6.3% of the total aerosol deposited in the lung, a similar 
deposition rate to larger pigmentary TiO2 particles. [98] While size is an 
important factor influencing nanomaterial deposition, the morphology of 
the lung, the respiratory conditions, and the physicochemical properties of 
the particles also influence deposition. [80] 
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 4.1.2 Biopersistence of TiO2 nanomaterials.  TiO2 particulates as 
a dust are categorized as a poorly soluble particulate (PSP), meaning they 
are unlikely to dissolve within the body. [75] It has been recommended 
that toxicology studies of PSP materials monitor post-exposure periods for 
at least 3 months because of the biopersistence of the materials in the 
lung. [99] TiO2 nanomaterials may be retained for even longer than larger 
TiO2 particulates because they can penetrate into lung tissues making 
macrophage clearance more difficult. [100] This longer clearance of 
nanomaterials is demonstrated in a study that showed the amount of TiO2 
nanomaterials in the avelolar space was not significantly different than fine 
TiO2, but the total retention was greater for the nanosize TiO2 because the 
particles had translocated into the pulmonary interstitium and persisted 
there. [79] 
 One measurement of biopersistence is half-life, or the time it takes 
for half of the total burden to be cleared.  When rats were exposed to a 
nebulized solution of P25 TiO2 nanoparticles at a high concentration (10 
mg/m3), the TiO2 had a half-life of 395 days. [99] Another study of P25 
showed similar results; after one year the original burden had decreased 
57% in rats and 45% in mice. [75] Other studies with TiO2 of similar 
primary particle size showed much faster clearance.  One study 
demonstrated a decline of 51% after just 5 weeks and another showed 
24% clearance in just 2 weeks.  However, both determined that the 
particles had formed large agglomerates (200-300 nm diameter) in the 
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aerosol. [98, 101] Just as agglomeration affected the deposition rate, so 
too does it affect the clearance rate. The agglomeration size for deposition 
and clearance may be even more important than the primary particle size. 
[102] The dosage also affects the clearance rate.  Higher dosages can 
result in a linear decrease of the lung burden, while lower dosages tend to 
have an exponential decay. [75] 
 4.1.3 Differences in TiO2 nanoparticle morphology.  Though 
many toxicology studies use P25 TiO2 as a standard material, it is not 
representative of all types of TiO2 nanomaterials.  The crystal structure 
and particle shape are important factors as well.  Exposure to anatase 
TiO2 nanoparticles has been shown to produce significantly more 
pulmonary inflammation and lung tissue damage than rutile TiO2 
nanoparticles of the same size. [103] It has been theorized that anatase 
TiO2 nanoparticles are more toxic because the crystal structure allows for 
a greater interaction between the DNA in the cells and the nanoparticles. 
[104] The anatase TiO2 nanoparticles have been shown to be more readily 
taken up by cells. [102] The greater uptake can cause an increased 
retention time within the lung.  This means that anatase nanoparticles can 
have a different toxicity level and different deposition and clearance rates 
than rutile nanoparticles.  Alteration of TiO2 nanomaterials to create a fiber 
structure like a nanobelt can cause an even greater increase in toxicity.  
TiO2 nanobelts have been shown to be highly toxic, much like asbestos 
fibers. [105] TiO2 nanobelts may have different deposition and clearance 
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rates as well because of their length.  All TiO2 nanoparticles are likely to 
have a higher deposition rate and increased cytotoxicity than larger TiO2 
microparticles like E171 that is used as a food additive. 
4.2 PROBLEM STATEMENT 
 The morphology of TiO2 nanomaterials has been shown to have an 
effect on deposition and clearance in the lung.  This project intended to 
study how three different morphologies of TiO2 nanomaterials—anatase 
nanoparticles, rutile nanoparticles, and nanobelts—affect the deposition 
into the lungs of rats after intratracheal instillation, and the clearance rate 
of the particles 1 day and 1 week after instillation by collaborators at UC-
Davis.  The rat lungs were digested to measure the total Ti in the lung.  
The digestion results were compared to the fraction of cells lavaged from 
within the lungs that have visible TiO2 particles found inside the cell 
membrane. 
4.3 MATERIALS AND METHODOLOGY 
4.3.1 TiO2 nanomaterials.  Three types of TiO2 nanomaterials 
were evaluated for their deposition and clearance in rat lungs.  P25 TiO2 
nanoparticles were supplied by the Evonik DeGussa Corporation that 
consist of a 81%/19% anatase/rutile TiO2 crystal structure mix with an 
average primary particle size of 24 nm.  The P25 is referred to as “Rutile.”  
Another TiO2 nanoparticle with a 100% anatase crystal structure and a 26 
nm primary particle size was produced at Rochester University.  This pure 
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anatase nanoparticle is referred to as “Anatase”.  TiO2 nanobelts were 
also evaluated, but no characterization data was provided. 
4.3.2 Animals.  The rats used in the instillation study were male 
Sprague-Dawley rats.  The rats were 6-8 weeks of age upon being 
received and 8-10 weeks of age during instillation.  The rats were received 
by the University of California-Davis from Hilltop Labs in Scottsdale, PA.  
All studies of the animals while they were alive were conducted at 
University of California-Davis. 
 4.3.3 Dispersion method.  The nanoparticles were dispersed in a 
dispersion media composed of a phosphate buffered solution of glucose 
with dipalmitoyl phosphatidyl chlorine at 10 μg/mL and albumin at 0.6 
mg/mL.  The dispersion was probe sonicated on ice for 30 minutes.  The 
total energy input was approximately 3700 J. 
4.3.4 Intratracheal instillation.  Suspensions were created at 
concentrations of 0, 20, 70, and 200 μg TiO2 per 250 μL of each type of 
nanomaterial.  The rats were lightly anesthetized using isoflurane in an 
airtight chamber before intratracheal instillation with 250 μL of suspension.  
The rats were then monitored until their scheduled necropsy date. 
4.3.5 Broncoalveolar lavage.  The rats were sacrificed either 1 
day or 7 days post-instillation.  The ribs were cut to expose the lungs and 
5 separate aliquots of 5 mL of sterile saline solution were pushed through 
the trachea and recovered.  The total 25 mL of saline solution were 
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retained for cell count analysis, cell type analysis, and biochemical 
analysis (results not shown here).  After broncoalveolar lavage, the lung 
tissue was harvested and frozen. 
4.3.6 Digestion.  The right caudal and right cranial lung lobes of 
the animals exposed to the highest dosages of nanoparticles (200 μg/ 250 
μL) were shipped on dry ice to Arizona State University for quantification 
of total TiO2.  Each lobe was digested individually.  Since the moisture 
content of the rat lungs is variable, the lungs were dried overnight in the 
microwave vessels at 80°C to assess Ti concentrations per dry mass.  It 
was found that after 8 hours the weight of the lung mass no longer 
decreased.  The microwave vessels were weighed before and after the 
lungs were dried to find the dry mass.  The lungs were then microwave 
digested at 180°C according to the settings listed in Table 3.1 with 2 mL 
HF and 8 mL HNO3 to break down the tissue and the TiO2.  This method is 
described in detail in Chapter 3.  There was one difference in the method 
used for the rat lungs rather than the tripe.  The rat tissue dry mass was 
so small (20-50 mg typically) that no hydrogen peroxide was needed after 
microwave digestion during the acid evaporation to further digest the 
organics (See Appendix D, Photo D.5).  Ti was quantified using the same 
ICP-MS analysis procedure detailed in Chapter 3.  A study using a similar 
method of microwave digestion for Ti quantification of rat lungs with HF 
and HNO3 demonstrated a 102% +/- 4.8 recovery. [87] Method blanks 
were run every 12 samples. 
66 
 
4.3.7 TiO2 nanomaterial cell inclusion counts.  The lavaged fluid 
was analyzed by microscopy to determine what fraction of the cells had 
observable TiO2 nanoparticles within the cell membranes.  500 cells from 
each animal were observed to determine whether TiO2 nanoparticles had 
entered the cells or not.  The cell counts were then compared to the Ti 
concentrations to determine the correlation.  All microscopy work and cell 
inclusion counts were conducted at UC-Davis 
4.4 RESULTS 
 4.4.1 Digestion results.  Lobes from 66 animals were digested.  
Lobes were only examined from the animals exposed to the highest 
dosage of each nanomaterial, which was 200 µg/250 µL.  Since each 
animal was instilled with 250 µL, the maximum mass in the lungs would be 
200 µg if all the TiO2 deposited.  The total Ti in each lung lobe sample 
varied greatly from animal to animal.  The largest amount of Ti was found 
in the caudal lobe of animal P1148.  The animal had been exposed to 
anatase TiO2 nanoparticles and 51.9 μg of Ti remained in the lung 1 day 
post-instillation.  The largest amount of Ti found in a cranial lobe was 
found in animal P1110.  The animal had been exposed to rutile TiO2 
nanoparticles and 8.1 μg of Ti remained in the lung 7 days post-instillation.  
However, the values varied greatly with some animals appearing to have 
virtually no Ti in either lobe.  The method blank average was 0.29 μg +/- 
0.12 µg (n=12) of Ti per sample and was consistently low.  The larger 
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caudal lobes tended to have more total Ti than the cranial lobes.  The 
results are shown in Figure 4.1. 
 
Figure 4.1.  Total Ti mass in rat lungs determine by microwave digestion. 
 The Ti mass was used to calculate the mass of TiO2 that was 
deposited and then normalized to the dry weight of each lung lobe.  Again, 
the normalized TiO2 in each lung lobe sample varied greatly from animal 
to animal.  The highest normalized concentration of TiO2 was found in the 
caudal lobe of animal P1148.  The animal had been exposed to anatase 
TiO2 nanoparticles and 3.46 μg TiO2/mg dry tissue remained in the lung 1 
day post-instillation.  The highest normalized concentration of TiO2 found 
in a cranial lobe was found in animal P1206.  The animal had been 
exposed to TiO2 nanobelts and 0.72 μg TiO2/mg dry tissue remained in 
the lung 7 days post-instillation.  The larger caudal lobes tended to have a 
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higher concentration of TiO2, but the difference between caudal and 
cranial lobes was smaller than the total titanium mass difference between 
lobes.  This is because the average mass of the caudal lobes was twice 
as much as the cranial lobes.  The results are shown in Figure 4.2. 
 
Figure 4.2.  Normalized TiO2 concentration in rat lungs. 
 4.4.2 TiO2 nanomaterial comparison.  Despite all animals being 
exposed to the same dosage of TiO2 nanomaterials, certain morphologies 
were more likely to be found in the lung.  In the caudal lobes, a greater 
mass of the anatase TiO2 nanoparticles were detected meaning that they 
deposited to the highest degree.  After 7 days the average mass of TiO2 
had lower than one day.  The rutile TiO2 nanoparticles and TiO2 nanobelts 
deposited to approximately the same degree.  The rutile and nanobelt 
TiO2 mass remained relatively constant from day 1 to day 7.  The average 
1
10
100
1000
10000
M
et
h
o
d
 B
la
n
k
P
11
17
P
11
28
P
11
47
M
et
h
o
d
 B
la
n
k
P
11
93
P
11
98
P
12
01
M
et
h
o
d
 B
la
n
k
P
12
14
P
12
23
P
10
47
M
et
h
o
d
 B
la
n
k
P
10
58
P
10
67
P
10
70
M
et
h
o
d
 B
la
n
k
P
10
93
P
10
96
P
10
99
M
et
h
o
d
 B
la
n
k
P
11
20
P
11
39
P
11
50
n
g 
Ti
O
2
/m
g 
D
ry
 L
u
n
g
Caudal Lobes
Cranial Lobes
69 
 
titanium masses depositing in the caudal lobes for each TiO2 nanomaterial 
morphology are shown in Figure 4.3. 
 
Figure 4.3.  Average mass deposited in caudal lobe by nanomaterial type.  
Error bars represent the standard deviation of the TiO2 mass for the 
sampled lung lobes. 
In the cranial lobes, there was no significant difference in deposition 
between nanomaterial morphology.  There was also no trend in clearance 
with the rutile nanoparticles and nanobelts actually having a higher mass 
remaining in the lung after 7 days compared to 1 day.  The average 
titanium mass depositing in the cranial lobes for each TiO2 nanomaterial 
morphology are shown in Figure 4.4. 
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Figure 4.4. Average mass deposited in cranial lobe by nanomaterial type.  
Error bars represent the standard deviation of the TiO2 mass for the 
sampled lung lobes. 
The normalized TiO2 concentration in the lungs followed the same 
trends as the total mass.  The anatase TiO2 nanoparticles had a higher 
concentration in the caudal lobes than either of the other two TiO2 
nanomaterial morphologies.  The concentration decreased after 7 days for 
the anatase particles, increased for the nanobelts, and remained relatively 
constant for the rutile particles.  The concentrations in the cranial lobes 
were much lower than the caudal lobes for all morphologies.  The 
normalized TiO2 concentrations deposited in the cranial lobes for each 
TiO2 nanomaterial morphology are shown in Figure 4.5. 
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Figure 4.5.  Normalized TiO2 concentrations in both caudal and cranial 
lobes for all TiO2 morphologies.  Error bars represent the standard 
deviation of the TiO2 concentration for sampled lung lobes. 
 4.4.3 Lung clearance significance.  When comparing the caudal 
lobe TiO2 concentrations from 1 day post instillation to 7 day post 
instillation, it was necessary to determine if the levels changed a 
significant amount.  The 90% confidence interval was determine based on 
the standard deviation and sample size for each of the morphologies 1 
day post instillation.  No morphology had a difference 7 days post 
instillation that was outside of the 90% confidence interval.  The same was 
seen for an 80% confidence interval.  When applying a 70% confidence 
interval to the 1 day instillation concentration means, the nanobelt TiO2 
concentration was outside of the confidence interval.  However the 
concentration actually had increased rather than decreased from day 1 to 
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day 7.  The decrease of concentration of the anatase nanoparticles was 
only deemed significant outside of a 60% confidence interval.  The TiO2 
mean 1 day concentration for each morphology can be seen with the 
confidence levels in Figure 4.6 along with the TiO2 mean 7 day 
concentrations. 
 
Figure 4.6 Caudal lobe mean TiO2 concentrations for 1 day post instillation 
with various confidence levels as well as the 7 day post instillation. 
4.4.4 Cell inclusion results.  For each animal, the broncoalveolar 
lavage fluid was analyzed at UC-Davis to determine what fraction of the 
cells had TiO2 nanoparticles within the cells.  The resulting counts are in 
number of cells with visible particles per 500 cells.  The data is for each 
animal rather than each lobe because the solution is lavaged through the 
whole lung.  The nanobelts could not be clearly seen in the cells for all of 
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the animals so there are no cell count data for the animals exposed to the 
nanobelts.  One successful image using cross polarized light of TiO2 
nanobelts within a cell is shown in Figure 4.9, however the same 
technique did not work for all of the samples.  Of the animals exposed to 
the anatase and rutile nanoparticles, the number of cells with TIO2 
nanoparticles in the cells varied greatly from animal to animal.  The 
highest number of cells with visible TiO2 nanoparticles was animal P1110.  
The animal had been exposed to rutile TiO2 nanoparticles and had 148 
cells with visible particles from the lavage 7 day post-instillation.  The 
animals exposed to the anatase TiO2 nanoparticles that were lavaged 
after one day had the highest number of cells with visible particles.  The 
number decreased at 7 days.  The number of cells with rutile particles was 
less than the anatase and actually increased from day 1 to 7.  The results 
for each animal are shown in Figure 4.7 and the average for each type of 
nanoparticle is shown in Figure 4.8. 
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Figure 4.7. Number of cells with visible TiO2 nanomaterials.  Data provided 
by UC-Davis 
 
Figure 4.8 Average results for the number of cells with visible TiO2 
nanomaterials. Error bars represent the standard deviation of the cell 
counts.  Data provided by UC-Davis. 
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Figure 4.9. Animal P1229 broncoalveolar lavage cells with TiO2 nanobelt 
inclusions.  Shown at 40x.  Image provided by UC-Davis. 
 The results of the cell count microscopy and the lung digestions 
were compared to determine if there was a good correlation between the 
two methods of determining the TiO2 nanomaterial lung burden.  There 
was a positive correlation between the two metrics.  A linear regression 
line was applied to the data and the R2 value was 0.376.  A plot of the 
TiO2 concentration compared to the cells with visible particle numbers is 
shown in Figure 4.10. 
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Figure 4.10 Correlation between cells containing visible TiO2 particles and 
the TiO2 concentration in the caudal lobes. 
4.5 DISCUSSION 
The study shows that with equal doses of TiO2 nanomaterials, the 
anatase particles are more likely to deposit in the lung.  The anatase 
nanoparticles appeared to clear from the lung from 1 day post-instillation 
to 7 days post-instillation.  No clearance trend can be observed in any of 
the other nanomaterials.  This is could be because the study did not last 
long enough.  As stated in the introduction of this chapter, a toxicology 
study should observe the animals for at least 3 months post exposure.  
Thus, any difference from day 1 to day 7 could just as easily be attributed 
to inefficient instillation or differences between the animals rather than 
actual clearance from the lung.  Most of the TiO2 nanomaterials deposited 
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in the caudal lobe rather than the cranial lobe.  When TiO2 was observed 
in the cranial lobe it was also observed in the caudal lobe, however the 
converse was not necessarily true.  The concentration data for the cranial 
lobes may have a larger degree of error than the caudal lobes because 
when the cranial lobes were dried, their mass was so small that even 
small errors in the weight can cause a high percentage of uncertainty.  
The average mass was only 24.7 mg. 
A number of lungs had Ti concentrations so low it appeared that 
there was no exposure.  Many of these were verified by the cell inclusion 
counts because no cells were observed with particles.  This is likely 
because the instillation method does not always work.  Sometimes rather 
than being instilled in the lungs, the solution is swallowed.  There are other 
factors that can show why the correlation between the two lung burden 
metrics did not show a better correlation.  Only 2 lobes of the lung were 
digested, but the lavage was from the total lungs.  The instillation could 
have all gone into the left lobes which would cause there to be a large 
number of cells with visible particles, but a low concentration from the 
digestion of the right lobes.  How the instilled solution was distributed 
through the lungs would change the Ti concentration determined by the 
right lobes for the same overall deposition rates.  However, it was a good 
sign that there were no false positives from the digestion method; any 
lobes that measured significant TiO2 concentrations had observable TiO2 
in the cells. 
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4.6 SUMMARY 
 Anatase TiO2 nanoparticles deposited in rat lungs to a greater 
degree than rutile nanoparticles or nanobelts with an average of 41 
µg of Ti found in caudal lobes 1 day after exposure to anatase TiO2.  
This was 218% higher than the second highest average 
concentration. 
 The anatase TiO2 nanoparticles were also found at the highest 
concentration in the caudal lobes with 1236 ng Ti/mg dry tissue as 
the average. 
 TiO2 nanoparticles concentration  were found to be 58% higher in 
caudal lobes than in the cranial lobes for anatase TiO2.  Similar 
trends were observed for all morphologies. 
 There was no significant evidence that there was less TiO2 material 
in the lung 7 days after instillation when compared to 1 day after 
instillation for all morphologies.   The Ti concentration had 
increased beyond the 80% confidence interval level for nanobelts 
from day 1 to day 7. 
 The Ti lung concentrations from the digestion of the lungs showed 
an R2 agreement of 0.376 with cell inclusion counts conducted with 
microscopy. 
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CHAPTER 5:  NANOSCALE FRACTION OF TITANIUM DIOXIDE USED 
IN FOOD PRODUCTS 
5.1 INTRODUCTION 
 TiO2 is used in as an additive in foods for coloring because—as a 
microparticle—it has a bright white color. [106] A very low amount of Ti is 
naturally occurring in foods, especially vegetables, because of the high Ti 
content in the soils.  Soybeans and shrimp with no additives were 
measured to have a Ti concentration of 3.23 μg/g and 2.52 μg/g 
respectively. [76] However, for the most part Ti and more specifically TiO2 
found in foods is included as an additive. 
 5.1.1 Pigmentary TiO2 additives.  TiO2 is added as a whitening 
agent to foods like dressing, gum, icing, cookies, and candies in a 
primarily microparticle form that is known as E171. [107] TiO2 is also 
sometimes used as an additive to create a barrier between layers of 
different colors in foods. [108] TiO2 is an ideal pigment because it is stable 
to heat, light, oxygen, and pH making it unaffected by almost any food 
processing. [106]  These same qualities make it resistant to degradation in 
the body.  TiO2 is used as an inert marker for studies of the digestibility of 
foods in animals. [81] The digestive system is exposed to exogenous, 
inorganic microparticles.  The most common of these microparticles are 
TiO2 and silicates.[109]  A western diet may expose the gastrointestinal 
(GI) tract to as many as 1012 inorganic microparticles per day from food 
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additives. [110]  TiO2 used as a color additive may results in the ingestion 
of up to 112 mg of Ti per person per day. [109] 
 The Food and Drug Administration (FDA) regulates food safety in 
the United States.  They have recognized synthetically prepared TiO2 as a 
color additive in foods.  The U.S. Code of Federal Regulations states that 
“any color additive intended solely for coloring purposes shall be labeled.” 
[111]  However, it has been shown that many foods that contain TiO2 do 
not list TiO2 as an ingredient, and those that did gave no indication of how 
much TiO2 is included in the product. [108] 
 5.1.2 TiO2 nanomaterials in food.  Nanomaterials engineered 
specifically to be used as food additives are uncommon because at such a 
small size they lose their white coloring, but they are increasingly being 
used in other areas of the food production industry. [112] Nanotechnology 
has been applied in agriculture cultivation, food processing, food 
packaging, and water purification. [113] TiO2 nanomaterials specifically 
have been used in the food industry for their photcatalytic antimicrobial 
properties.  TiO2 nanomaterials used with UV light have been shown to 
increase the quality and shelf life of food by reducing the bacteria. [114, 
115] TiO2 nanotubes and TiO2 nanopowders have been used for food 
packaging and have been shown to cause an inactivation of E. Coli, 
Salmonella, and Staph bacteria. [116, 117] TiO2 nanomaterials have been 
applied in films onto steel and glass surfaces used in the food processing 
industry to prevent biofilms from growing on the surfaces. [118, 119] As a 
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result of the increased use of nanotechnology in the food production 
industry, there is an increased likelihood that TiO2 nanomaterials may 
ultimately end up in the food products from contact with packaging or 
coated surfaces.  Other ways have been proposed that TiO2 may enter 
into the food chain.  TiO2 nanoparticles with a diameter less than 5 nm can 
be taken up by plants and it has been hypothesized that they may 
biomagnify as they move up the food chain. [120] So while TiO2 
nanomaterials may not specifically be engineered to be food additives; 
they can still end up in food products. 
Ingesting food products is the primary way that TiO2 may enter the 
digestive system, but it is not the only way. [61]  TiO2 that is cleared from 
the lungs by the mucocilliary is often swallowed.  TiO2 may be accidently 
ingested by those in TiO2 production facilities or by hand-to-mouth contact 
after using personal care products containing TiO2. [112] New medical 
products are using TiO2 nanomaterials that may reach the digestive 
system. [121] There are numerous ways that TIO2 nanoparticles can enter 
the digestive system in addition to the ingestion of food. 
 5.1.3 Effects caused by ingestion of TiO2 microparticles.  
Though TiO2 is not readily degradable by the body and up to 98% may 
pass through the digestive system and be recovered in the fecal matter, 
there can still be some slight absorption by the GI tract. [81] 500 nm 
particles orally exposed to rats were found in all major gastrointestinal 
associated lymphatic tissues (GALT) with limited translocation to the liver 
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and spleen. [63] Macrophages in the GALT actually become loaded with a 
dark pigment from aluminum, silicon, and titanium microparticles, with a 
significant amount coming from TiO2 spheres with a diameter of 100-200 
nm that are believed to have come from coloring additives. [122] Though 
microparticles like TiO2 have a limited effect on macrophages; they can 
aggravate ongoing inflammatory responses in the GI tract. [110] 
 Crohn’s disease can cause an inflammatory response in the GI 
tract.  Similarly to how asthma patients are sensitive to microparticle 
exposure in the air, patients with Crohn’s disease are sensitive to 
microparticles in food. [123] It has been shown that a diet low in 
microparticles like TiO2 color additives can alleviate the symptoms of 
Crohn’s disease. [124] It has been hypothesized that negatively charged 
TiO2 particles in the gut may bind metal cations that are then coated with 
inflammatory bacterial anions. [123]  TiO2 microparticles may often be 
described as inert, but there are acute effects in the body, especially to 
those with preexisting inflammatory conditions in their GI tract. 
 5.1.4 Effects caused by of ingestion TiO2 nanomaterials.  
Similar to TiO2 microparticles, TiO2 nanomaterials are capable of being 
absorbed by the GI tract to a small degree.  The reason more TiO2 is not 
absorbed is that the absorption occurs primarily through the Peyer’s 
Patches in the intestine.  These patches only occupy a small fraction of 
the surface area in the intestine. [61] At high concentrations (> 10 μg/mL), 
TiO2 nanomaterials in the intestines can cross the epithelial lining at low 
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levels. [41] From the GALT, orally administered TiO2 nanoparticles of 25 
and 80 nm diameter both translocated to the liver, kidney, and spleen, but 
with no obvious acute toxicity. [33] TiO2 nanomaterials ingested by 
terrestrial isopods showed a decrease in activity of antioxidant enzymes, 
but no effects were observed on higher level endpoints like weight, 
feeding habits, or survival. [125] Addition of TiO2 nanomaterials to the food 
of terrestrial invertebrates caused similar effects and was controlled by the 
duration of exposure rather than total dose, a trend that is different than 
soluble chemicals. [126] 
 5.1.5 Release of TiO2 nanomaterials to the environment.  
Ingested TiO2 nanomaterials may cause some acute effects on humans 
and other organisms, but the majority of the ingested dose passes through 
the body and end up in fecal matter. [81] It has been shown that TiO2 from 
human waste ends up in wastewater and eventually at WWTPs. [46, 47] 
From WWTPs TiO2 nanomaterials can be released to the environment.   
5.2 PROBLEM STATEMENT 
 TiO2 nanomaterials may end up in food products from packaging 
and processing.  However, they are not as prevalent as TiO2 
microparticles used in food products as a coloring additive.  The size of 
pigmentary TiO2 microparticles is not uniform, but rather a distribution of 
sizes.  It is hypothesized that some of the particles included in pigmentary 
TiO2 are in the nanoscale range.  This research project intended to study a 
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number of foods with and without TiO2 listed as an ingredient to determine 
if TiO2 is present.  The total TiO2 was quantified to understand the total 
TiO2 mass a person may be exposed to from a normal diet.  The smallest 
particles were isolated and quantified to better understand the size 
distribution of TiO2 used as a food coloring additive and if TiO2 
nanoparticles are included in pigmentary TiO2. 
5.3 MATERIALS AND METHODOLOGY 
 5.3.1 Food products.  Eighty nine different food products were 
purchased in Arizona grocery stores in March 2011.  Different types of 
products were chosen—many because they were white—including 
sauces, dairy products, confectionaries, candies, beverages, chocolates 
and gums.  These products were more likely to have additives then foods 
with limited processing like fruits, vegetables, and unprocessed meat.   
Attempts were made to purchase at least 2 brands of each product, 
usually a name brand and a separate generic brand.  Samples were 
transported to the laboratory and stored in a clean, dry cupboard or 
refrigerated and analyzed prior to expiration dates listed on the product 
labels.  Information about the products, including the serving size and 
whether or not TiO2 was listed on the label was recorded. 
5.3.2 Digestion.  For samples with serving sizes measured by 
mass, 500 mg of each food were weighed and added to a clean 
microwave digestion vessel.  Foods were weighed as is rather than dried 
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because serving sizes are not based on dry weight.  For samples with 
serving sizes measure by volume, 5 mL of each food or beverage were 
pipetted into a clean microwave digestion vessel.  The foods were then 
microwave digested at 180°C according to the settings listed in Table 3.1 
with 2 mL HF and 8 mL HNO3 to break down the tissue and the TiO2.  This 
method is described in detail in Chapter 3.  Some of the foods with a large 
amount of organics were not totally broken down by the initial 2 mL of 
hydrogen peroxide added after digestion.  As the liquid was evaporated, if 
it became apparent that there was organic material remaining in the 
sample, it was cooled and then 2 mL of hydrogen peroxide was added and 
the sample was heated again.  It is important to note that samples with 
high concentrations of Ti will turn orange with the addition of peroxide in 
an acidic environment. [83] (See Appendix D, Photo D.9) Ti was quantified 
using the same ICP-MS analysis procedure detailed in Chapter 3.  All 
samples with Ti concentrations outside of the calibration range were 
diluted and re-analyzed.  A study using a similar method of acid digestion 
for Ti quantification in food matrices demonstrated a precision of typically 
1% or better. [81] Method blanks were run every 12 samples and the 
average for the blanks was 0.58 μg +/- 0.29 from 12 method blanks. 
5.3.3. TiO2 materials.  The digestion method was evaluated for 
recovery of TiO2 nanoparticles and TiO2 microparticles in a food matrix.  
50 mg of each material was spiked into 500 mg of chocolate.  Chocolate 
was chosen because it is known to have a very low concentration of TiO2 
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so an accurate recovery percentage can be determined.  It is also 
relatively difficult to digest for a food.  The microparticles used were E171 
pigmentary TiO2 purchased from Fiorio Colori Spa in Italy with an average 
primary particle size of 110 nm.  The nanoparticles used were P25 TiO2 
purchased from the Evonik DeGussa Corporation with an average primary 
particles size of 24 nm.  Each TiO2 nano powder was analyzed by SEM to 
determine the primary particle size.  The E171 TiO2 particles were then 
dispersed in nanopure water with Bovine Serum Albumin (BSA).  The P25 
TIO2 particles were dispersed in nanopure water and the solution was 
sonicated for 30 minutes according to the stock preparation method 
described in Appendix B.  Solutions were analyzed using phase analysis 
light scattering (PALS) to identify the size distribution and find the average 
aggregate size after dispersion. 
5.3.4 Separation method.  In order to determine how much TiO2 is 
in the nanosize range a separation method had to be created to separate 
smaller TiO2 from larger TiO2 and organic materials.  500 mg of a food 
sample was added to a beaker.  The organic material from the food was 
broken down by adding 10 mL of hydrogen peroxide and 0.5 mL of HNO3 
and heating on a hot plate at 110°C.  When the volume of liquid remaining 
in the sample was less than 1 mL, the beakers were removed from the hot 
plate and allowed to cool.  The beaker sides and bottom were then rinsed 
with approximately 20 mL of nanopure water.  The sample was filtered 
with a 0.45 µm nylon filter and added to a microwave vessel.  To 
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determine the total TiO2 that was able to pass the 0.45 μm filter the 
sample was then digested using the microwave digestion with HF and 
HNO3.  For microscopy analysis, after the sample was filtered with a 0.45 
μm nylon filter, it was poured into a 25 mL volumetric flask and filled to the 
25 mL mark with nanopure water.  In this way the final concentration of the 
undigested TIO2 particles that pass the 0.45 μm filter will be the same as 
the concentration of the digested TiO2 particles that pass the 0.45 μm 
filter.  A 0.45 µm filter was chosen because preliminary tests evaluating 
0.45 µm filters and GF/F filters (data not shown here) found that a 
measurable amount of Ti was able to pass both filters.  Since 0.45 µm 
filters have a smaller pore size than the 0.7 µm pore size of GF/F filter, the 
0.45 µm filter was selected to remove any particles larger than 450 nm.  
The pH of the samples was determined before filtration to ensure that the 
nylon filter would not be damaged during filtration. 
5.3.5 Microscopy.  The control TiO2 particles, E171 and P25 were 
analyzed by SEM to find the primary particle size.  P25 Nanoparticles had 
a more consistent particle diameter of 20-30 nm.  E171 had a wider 
variance in primary particle size with some being nanosized (< 100 nm) 
and others being as large as 250 nm in diameter.  (See Figure 5.1) 
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Figure 5.1. SEM images of E171 (left) and P25 (right) TiO2 materials. 
5.4 RESULTS 
 5.4.1 TiO2 particle characterization.  After dispersion in nanopure 
water the two TiO2 control particle solutions were analyzed by PALS and 
the results are shown in Table 5.1.  After dispersion the aggregate size of 
the P25 was still smaller than the primary size of the E171 and still 
nanosized (<100 nm). 
Table 5.1 
Primary Particle Size and Aggregate Size for TiO2 Control Particles. 
TiO2 Particle Primary Particle Size DLS (in BSA) 
E171 110 nm 380 nm 
P25 24 nm 60 nm 
 
 5.4.2 TiO2 recovery tests.  The recovery of two different types of 
TiO2 was each greater than 80%.  The samples were run in triplicate and 
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the standard deviation was approximately 2.5%.  The average Ti from the 
chocolate was less than 0.1% of the 50 mg P25 and E171 added to the 
samples.  The recoveries are shown in Table 5.2. 
Table 5.2 
Digestion Recovery for P25 and E171 TiO2. 
TiO2 Particle P25 50 mg E171 50 mg 
Recovery 81 % 87 % 
Standard Deviation (n=3) +/- 2.7 % +/- 2.3 % 
 
 5.4.3 Total TiO2 in food.  All eighty nine foods were digested and 
the concentration of Ti in the food was determined.  16 of the foods were 
digested in triplicate.  The agreement amongst the triplicates was good, all 
within 30%.  The blank average was 0.579 μg.  The highest concentration 
in any food was Dickinson’s Coconut Curd at 3.59 μg/mg.  The rest of the 
Ti concentrations spanned 5 orders of magnitude with some foods having 
levels below the detection limit for the method.  The 20 highest Ti 
concentrations in food are shown in Figure 5.2.  The concentrations for all 
89 foods are shown in Appendix A, Figure A.1. 
 The gum products consistently had some of the highest 
concentrations of Ti of any products.  The 5 gums that were analyzed all 
were within the top 17 products in terms of Ti concentration all with greater 
than 0.12 µg Ti/mg.  Of those 5 gum products, the cinnamon gum that had 
a red coating was the lowest.  The white colored gums made up 4 of the 
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13 foods with the highest Ti concentration.  It is important to note that all 
the gum products were the types of gum with a hard shell coating the 
gum-based center.  Other candy products that had a hard outer shell also 
had high Ti concentrations.  The candy products wither hard shells 
(M&Ms, M&Ms with peanuts, and Good and Plenty) all were in the top 10 
for Ti concentration.  When you combine the gums and candies into a 
more general hard shell candy category, 8 of the 17 products with the 
highest Ti concentrations would fall into the hard shell category. 
 Another group of food products that was well represented in the top 
20 highest Ti concentrations were powder products that were mixed into 
foods.  Two brands of Kool-Aid drink mix were in the top 14 for products 
with the highest concentration of Ti.  Albertson’s Vanilla Pudding and Jell-
O Banana Pudding were ranked at 8th and 12th respectively.  However, 
other powdered products like Carnation Instant Breakfast and Nestle 
Coffee Mate had much lower concentrations at 33rd and 61st highest with 
less than 0.015 µg Ti/mg for both products. 
 Chocolate products that did not have a hard outer shell had much 
lower concentrations compared to those with a shell.  Hershey’s Special 
Dark chocolate bar had the highest concentration for chocolate products 
without a shell at 0.0050 µg Ti/mg.  This can be compared to M&Ms which 
had a Ti concentration of 1.25 µg Ti/mg.  Dairy products like cheeses, 
mayonnaise, routinely had low concentrations of Ti with 10 of the 12 
products with the lowest Ti concentrations were dairy products.  The 
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highest of any dairy product was Albertson’s American Single cheese with 
0.0069 µg Ti/mg which ranked it 37th on the food product list.   
There was generally not a significantly large difference between 
generic and name brand products.  The largest came between Albertson’s 
Mini Marshmallows at 0.307µg Ti/mg and Kraft Jet Puffed Marshmallows 
at 0.00255 µg Ti/mg.  However, other comparison products ranked were 
nearly identical.  For instance, Hershey’s Chocolate Syrup and Albertson’s 
Chocolate Syrup were measured at 0.0026 and 0.0025 µg Ti/mg 
respectively.  Likewise Nestle Coffee Mate and Albertson’s Coffee 
Creamer measured 0.040 and 0.036 µg Ti/mg respectively.   
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Figure 5.2.  Normalized Ti concentration in food products.  Error bars 
represent standard deviation from samples digested in triplicate. 
 Using the Ti concentrations, the amount of Ti consumed per 
serving was calculated.  Because the serving sizes are different, the foods 
that had the highest concentration Ti did not necessarily have the largest 
amount of Ti per serving.  The food with the highest Ti mass per serving 
was Hostess Powdered Donettes with 206 mg of Ti per serving.  The 20 
samples with the most Ti are shown in Figure 5.3.  The samples 
highlighted in red had TiO2 listed on the labels, all others omitted TiO2 
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from the label.  The Ti per serving for all the foods is shown in Appendix A, 
Figure A.2.  Samples in green measured below the MDL. 
 The foods with the highest concentrations of Ti did not necessarily 
have the highest amount of Ti per serving.  This was especially true for the 
gums which only had a serving size of 2 or 3 g depending on the brand.  
Since most other products had serving sizes ranging between 20 g and 60 
g, the absolute Ti ingested in products with a larger serving size might be 
higher than a serving of gum despite gum having a greater concentration 
of Ti.  The Ti mass per serving from the chocolate products were higher 
due to the high Ti concentrations in the shell products and the larger 
serving size of the products without a shell.  The M&Ms and M&Ms with 
peanuts had the 4th and 5th highest mass of Ti per serving at 60.2 and 45. 
3 mg per serving.  The Hershey’s Special Dark bar and Hershey’s Dark 
Chocolate Bliss had the 23rd and 24th highest mass of Ti per serving at 
0.22 mg and 0.19 mg respectively.  All the beverages ranked in the lower 
half of the products evaluated.  The Shamrock Farms Fat Free Milk was 
the highest of any beverage at 0.062 mg. 
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Figure 5.3.  Ti mass per serving of food products.  Foods displayed in red 
had TiO2 listed as an ingredient.  Error bars represent the standard 
deviation for foods digested in triplicate. 
 5.4.4 TiO2 fraction to pass a 0.45 μm filter.  The 12 food products 
with the highest concentration of Ti were filtered to determine what fraction 
of the total Ti was small enough to pass a 0.45 μm filter.  Only the 11 
foods with the highest concentration were chosen because preliminary 
studies (results not shown here) indicated that only a small percentage of 
the total Ti would pass through the filter.  Filtering a sample with a 
moderate level of Ti might move the concentration below the MDL.  The 
Dentyne Ice gum had the highest percentage of the total Ti pass through 
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the 0.45 μm filter at 3.86%.  Four of the samples had less than 0.5% pass 
through the filter.  The results for the filtration tests are shown in Figure 
5.4. 
 
Figure 5.4. Percentage of total Ti in foods that passed a 0.45 μm filter. 
5.5 DISCUSSION 
 All the results are expressed in Ti.  This is because, once digested, 
TiO2 dissolves into Ti ions, a necessary step for analysis by ICP-MS.  
However, since Ti is naturally present in foods at trace levels, Ti measured 
by digestion is almost totally included in food as TiO2.  There were high 
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levels of Ti even in samples that did not have TiO2 listed as an ingredient.  
A person could ingest several hundred mg of TiO2 each day by eating just 
a couple servings of the foods with large amounts of TiO2. [108] The foods 
with the highest concentrations of Ti were gums, candies with hard shell 
coatings, and white confectionary products. 
 The fraction of Ti that passed a through the filter was largely 
dependent on the type of food that was digested.  Though the white foods 
had large total quantities of Ti, generally less than 1% of it was able to 
pass through the filter.  It is important to note that the filters used had a 
collection efficiency of 99% for particles larger than 0.45 µm.  Thus, 1% 
passage may not mean that all the Ti that passed is actually nanosized, it 
could be larger particles.  Foods with hard shells like the gum and the 
M&Ms had a significant amount of Ti (>1%) that was able to pass through 
the filter.  It is important to realize that TiO2 that passes through the filter is 
not necessarily all of the TiO2 with a particle size smaller than 0.45 μm.  
From previous work (results not shown) particles with a smaller primary 
particle size may still be absorbed to the filter or they may form 
aggregates that are too large to pass through the filter. However, if some 
TiO2 materials can pass the filter and can be shown to be in the nano size 
range, then that is relevant to ingestion studies and as a key source for 
environmental releases. 
 
97 
 
5.6 SUMMARY 
 Foods that had the highest measured concentrations of TiO2 were 
those that were bright white, or those with a candy shell.  The 
highest concentration in any food was Dickinson’s Coconut Curd at 
3.59 μg/mg 
 TiO2 was found in foods at concentrations high enough that a 
person could ingest greater than 100 mg from a single serving.  
Hostess Powdered Donnettes had the highest mass from a single 
serving with 205 mg Ti. 
 Many foods did not list TiO2 as an ingredient, but still had relatively 
high concentrations of TIO2. 
 3.9% of Ti particles were small enough to pass through a 0.45 μm 
filter for Dentyne Ice gum, with 5 different foods having greater than 
1% passage. 
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CHAPTER 6:  NANOSIZED TITANIUM DIOXIDE USED IN PERSONAL 
CARE PRODUCTS  
6.1 INTRODUCTION 
 6.1.1 TiO2 nanomaterials in personal care products.  TiO2 
nanomaterials are increasingly being used in personal care products 
(PCPs).  Their light dispersion properties make them ideal UV blockers for 
sunscreens and cosmetic products.  Both TiO2 and ZnO nanomaterials 
have been used to prevent damage to the skin by either absorbing or 
scattering the UV light.  They are often coated with organic materials in 
order to trap hydroxyl radicals that can damage cells.  TiO2 has been 
recognized as a UV blocker for decades, but TiO2 nanomaterials have 
become more popular lately because their size makes them transparent 
rather than a chalky white color. [9] In addition to being transparent, TiO2 
nanomaterials have been shown to have a higher sun protection factor 
(SPF) than larger TiO2 particles. [127] TiO2 and ZnO have an advantage 
over organic UV blockers because they are less like to cause an allergic 
reaction and have a higher photstability. [128] 
 TiO2 nanomaterials typically exist as aggregates of particles with a 
primary particle diameter of 30-150 nm.  The aggregates tend to be 
bounded so strongly that the force of application will not break them up. 
[129] The nanomaterials provided the best UV attenuation when they were 
less aggregated and more evenly distributed. [130] To increase 
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photostability and prevent aggregation, TiO2 nanomaterials are commonly 
coated with aluminum, silicon, or polymers. [131] Silica coatings were 
found to be the most effective at stabilizing the particles and minimizing 
any negative effects. [132] 
 Dermatological and health authorities recommend the use of 
sunscreen before any sun exposure as a photoprotective strategy to 
prevent cell carcinoma. [128, 133] A recent survey showed that one third 
of people questioned observe the advice of health experts, saying they 
use sunscreen regularly.  It is estimated that 33 million Americans use 
sunscreen every day and another 177 million use it occasionally. [9] 
Sunscreens and cosmetics are regulated by the FDA as over the counter 
drugs.  TiO2 nanomaterials are not considered to be a new additive, but 
rather a variation in particle size of an existing drug additive. [134] The 
only limitation stipulated by the FDA for sunscreens is that TiO2 
concentration be less than 25%.  Most tend to have a lower concentration, 
between 2% and 15%. [9]  With the wide prevalence of sunscreen use and 
the lack of a distinction between TiO2 nanomaterials and larger sized 
particles, the general public is being exposed to nanomaterials of which 
they are largely ignorant. 
 6.1.2 Risk associated with TiO2 used in PCPs.   The risk from a 
substance depends on the hazard potential as well as external exposure 
likelihood.  The application of sunscreens and cosmetics is one of the few 
times that the general public is intentionally exposed to nanomaterials.  
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The primary concern associated with the use of PCPs is dermal exposure, 
though they can be accidently ingested as well.  [112] The reason there is 
concern is that uncoated TiO2 nanomaterials can produce DNA damaging 
reactive oxygen species (ROS) and cause lipid peroxidation and protein 
tyrosine nitration which may cause cell death or lead to the onset or 
progression of diseases. [132, 135] Dermal studies tended to find anatase 
TiO2 nanomaterials to be more toxic. [136] 
 For these toxic effects to be relevant, TiO2 nanomaterials must be 
able to penetrate the epidermis and be distributed through the body.  
Dermal exposure is covered in more detail in Chapter 2.  Most studies on 
translocation of TiO2 nanomaterials through the epidermis found that they 
could not pass the stratum corneum or outermost layer of the epidermis 
and that the distribution appeared similar to that of larger TiO2 particles. 
[129] The studies that did observe nanomaterials in the dermis found that 
it was only a tiny fraction of the dose, with no significant penetration. [137] 
A minority of researchers claim that TiO2 nanoparticles do pose a 
significant threat from application to the skin.  Wu [138] argues that while 
no penetration into the dermis was observed in porcine skin conducted in 
vitro, there was significant penetration and distribution of TiO2 
nanomaterials in an in vivo study of hairless mice.  However, most 
literature reviews and studies claim that there is either no threat to human 
health or that the threat is negligible and the products can be considered 
safe. [129, 133] 
101 
 
 6.1.3 Characterization of TiO2 nanomaterials in PCPs.  In order 
to better understand the potential benefits and hazards of TiO2 
nanomaterials in PCPs, one must better understand their size distribution.  
A study on microscopy of TiO2 nanomaterials in PCPs found that 
transmission electron microscopy (TEM) and scanning electron 
microscopy (SEM) used together can provide an adequate 
characterization of the nanomaterials, and recommended using WetSEM 
as well to view the nanomaterials in the creams without having to dry them 
first. [18] Sedimentation field flow fractionation (FFF) has successfully 
been coupled with ICP-OES and ICP-MS for the size distribution 
characterization of both sunscreen and face cream. [19, 139]  These 
methods can all be used to provide better data about primary particle size, 
aggregation size, and concentration of TiO2 nanomaterials used in PCPs. 
 6.1.4 Environmental release and fate of TiO2 nanomaterials 
from PCPs.  Though it is generally agreed up that PCPs containing TiO2 
nanomaterials do not pose a significant health threat to humans, their 
safety does not mean their use is without consequence.  As people bathe 
and laundry is washed, the sunscreen and cosmetics end up in 
wastewater.  After treatment at WWTPs the water is returned to the 
environment.  Organic UV filters used in sunscreens have already been 
found in surface waters in Switzerland. [140] In the United Kingdom, 
concentrations of Ti small enough to pass a 0.45 µm filter were found to 
be 11 times higher than the background directly downstream of a WWTP. 
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[48] Discharge from WWTPs is an indirect source of sunscreen to the 
environment.  Sunscreen may also be introduced to the environment 
directly from recreational activities in lakes or pools. [9, 140] 
 As the sunscreen ages in the wastewater or surface water, TiO2 
nanomaterials can be released.  One study showed that the aging of 
sunscreen in natural waters caused 30% of the total TiO2 nanomaterials to 
be released.  Once released they created a stable dispersion of sub-
micron aggregates. [141] Another study observed similar results with TiO2 
nanomaterials forming a stable suspension of colloidal byproducts ranging 
in size from 50 nm to 700 nm.  The presence of natural organic matter 
(NOM) was found to be a contributing factor to colloidal stability. [131] 
6.2 PROBLEM STATEMENT 
 TiO2 nanomaterials are specifically included in PCPs like sunscreen 
and cosmetics.  The regular use and disposal of PCPs creates a large 
source of TIO2 nanomaterial releases to the environment.  This research 
project was intended to study a number of PCPs with and without TiO2 
listed as an ingredient to determine the mass concentration of TiO2 in the 
consumer products.  This provided an idea of how much TiO2 a person 
may use from normal application of the PCPs.  The smallest particles 
were isolated and quantified.   
 
103 
 
6.3 MATERIALS AND METHODOLOGY 
 6.3.1 Personal care products.  Thirty two different PCPs were 
purchased in Arizona grocery stores in March 2011.  Many different types 
of products were chosen including 3 deodorants, 1 lip balm, 6 shampoos, 
1 shaving cream, 13 sunscreens, and 8 toothpastes.  Different types of 
PCPs were selected including name brands and generic brands.  Samples 
were transported to the laboratory and stored in a clean, dry cupboard.  
Information about the products, including whether or not TiO2 was listed 
on the label was recorded. 
6.3.2 Digestion.  500 mg of each product was weighed and added 
to a clean microwave digestion vessel.  The products were then 
microwave digested with 2 mL HF and 8 mL HNO3 to break down the 
organic matter and the TiO2.  This method is described in detail in Chapter 
3.  Some of the products with a large amount of organics were not totally 
broken down by the initial 2 mL of hydrogen peroxide added after 
digestion.  As the liquid was evaporated, if it became apparent that there 
was organic material remaining in the sample, the sample was cooled and 
then 2 mL of hydrogen peroxide was added and the sample was heated 
again.  It is important to note that samples with high concentrations of Ti 
will turn orange with the addition of peroxide in an acidic environment. [83] 
(See Appendix D, Photo D.8).  Ti was quantified using the same ICP-MS 
analysis procedure detailed in Chapter 3.  All samples with Ti 
concentrations outside of the calibration range were diluted and re-
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analyzed.  A study using a similar method of acid digestion for Ti 
quantification in sunscreens demonstrated a recovery of 95%. [85] A 
recovery evaluation for TiO2 nanoparticles and microparticles was 
conducted in Chapter 5.   
6.3.3 Separation method.  In order to determine how much TiO2 is 
in the nanosize range a separation method had to be created to separate 
smaller TiO2 from larger TiO2 and organic materials.  500 mg of a product 
sample was added to a beaker.  The organic material from the sample 
was broken down by adding 10 mL of hydrogen peroxide and 0.5 mL of 
HNO3 and heating on a hot plate at 110°C.  When the volume of liquid 
remaining in the sample was less than 1 mL, the beakers were removed 
from the hot plate and allowed to cool.  The beaker sides and bottom were 
then rinsed with approximately 20 mL of nanopure water.  The sample 
was filtered with a 0.45 μm nylon filter and added to a microwave vessel.  
To determine the total TiO2 that was able to pass the 0.45 μm filter the 
sample was then digested using the digestion method.  The pH of the 
samples was determined before filtration to ensure that the nylon filter 
would not be damaged during filtration. 
6.4 RESULTS 
6.4.1 Total TiO2 in PCPs.  All 32 PCPs were digested and the 
concentration of TiO2 (determined as Ti) in the product was determined.  
The highest concentration of Ti in any sunscreen was found in Neutrogena 
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Sensitive Skin Sunblock Lotion at 70.1 μg/mg.  The highest concentration 
of Ti in any toothpaste was found in Sensodyne at 5.64 µg/mg.  The three 
sunscreens with TiO2 listed as an ingredient were the highest of any 
PCPs.  The toothpastes all had TiO2 listed as an ingredient and had a 
concentration one order of magnitude lower than the sunscreens made 
with TiO2.  The sunscreens without TiO2 listed on the label had 
concentrations of TiO2 that were three orders of magnitude lower than 
those with TiO2 listed.  The concentrations of TiO2 in the shampoo, lip 
balm, shaving cream and deodorant were all much lower with the highest 
concentration of any being in Head and Shoulders 2 in 1 shampoo at 
0.0056 µg/mg.  The results for the total titanium concentration for all the 
PCPs can be seen in Figure 6.1.  The values plotted in orange are the 
sunscreens that had TiO2 listed as an ingredient.  The values plotted in 
red are the toothpastes that had TiO2 listed as an ingredient.  All other 
products did not list TiO2 as an ingredient. 
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Figure 6.1.  Total titanium concentration for PCPs. 
 6.4.2 TiO2 fraction to pass a 0.45 μm filter.  PCPs with the 
highest concentration of Ti were further examined by digesting the 
organics and filtering with a 0.45 μm filter.  From preliminary experiments 
(data not shown here) it was known that only a small fraction of the total Ti 
can pass the filter so only the samples with a high concentration of Ti 
would have measurable concentrations after filtering.  Two of the 
sunscreens and 3 toothpastes with high Ti concentrations were selected.  
6.3% of the total Ti in the Neutrogena Pure and Free Baby sunscreen was 
able to pass through the filter which was the highest of any sample.  The 
sunscreens had a higher percentage of Ti that was able to pass through 
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the filter compared to the toothpastes.  Each of the toothpastes had less 
than 1% of the total Ti pass through the filter.  The results are displayed in 
Figure 6.3. 
 
Figure 6.3. Ti percentage to pass through a 0.45 µm filter from sunscreens 
and toothpastes. 
6.5 DISCUSSION 
. The TiO2 concentration in the consumer products tended to be 
more consistent than the wide range of concentrations seen in the food 
products.  The 3 sunscreens that used TiO2 as a UV blocker had TiO2 
concentrations on the same order of magnitude.  TiO2 in those sunscreens 
represented between 1.4% and 7% of the total mass which is similar to 
what was reported in the literature and listed on the ingredients. The 8 
toothpastes all had TiO2 concentration on the same order of magnitude.   
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All other PCPs did not have TiO2 listed and had noticeably lower 
concentrations meaning that unlike the food products, having TiO2 omitted 
on the label meant that there was likely a very low concentration of TiO2. 
 The sunscreens had a significant amount (3-6%) of Ti that passed 
through the 0.45 µm filter, more so than any of the foods evaluated in 
Chapter 5.  The toothpastes evaluated had less than 1% pass through the 
filter.  Since the filter has a 99% efficiency, the percentage of the 
toothpastes to pass through a 0.45 µm filter was not significant and could 
have been larger particles.  This means that the sunscreen had a larger 
fraction of small particles than the toothpastes indicating that the size 
distribution is closer to the nano range.   
6.6 SUMMARY 
 Sunscreens that had TiO2 listed as an ingredient had the highest 
concentrations of Ti with Neutrogena Sensitive Skin Sunblock being 
the highest with 70.1 ug Ti/mg. 
 All toothpastes had similar Ti concentrations, between 0.75 and 
5.64 ug Ti/mg. 
 PCPs that did not list TiO2 as an ingredient had Ti concentrations 
that were several orders of magnitude lower than those products 
with TiO2 listed as an ingredient with none being higher than 0.12 
ug Ti/mg. 
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 6.3% of the total Ti measured in Neutrogena Pure and Free Baby 
was able to pass through a 0.45 μm filter indicating a larger portion 
of small near-nanosized particles. 
 Less than 1% of the total Ti in the toothpastes was able to pass 
through a 0.45 μm filter.  
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CHAPTER 7:  NANOSIZED TITANIUM DIOXIDE USED IN PAINTS 
7.1 INTRODUCTION 
 7.1.1 Nanoscale TiO2 in paints.  TiO2 particles are used to whiten 
paints.  Nearly 90% of the total titanium mineral production is used for 
pigments in paints. [90].  TiO2 used in paints has a size distribution 
including some nanosized particles. The advantages of shifting TiO2 
production to a nanoformat mean that the size distribution is likely to shift 
even farther toward the nano range. [11] TiO2 nanoparticles with a 
diameter of 20-300 nm have been observed in surface waters and traced 
back to exterior paint as a source.  The TiO2 nanoparticles had detached 
under normal weather conditions. [21] The eventual TiO2 mass lost due to 
weathering from exterior paint is approximately 1.5 mg/m2.  Though this is 
a small portion of the total TiO2 mass in the paint (25,000 mg/m
2), it can 
add up to a large source of TiO2 to the environment when every painted 
façade is considered. [142]  
7.1.2 TiO2 nanomaterials used in coatings.  TiO2 nanomaterials 
are used specifically in coatings used in the automotive industry.  TiO2 
nanoparticles incorporated into polyurethane coatings caused an increase 
in resistance to weathering and enhanced mechanical properties. [143] 
Over time the wearing of the coating on automobiles will also cause the 
release of TiO2 nanomaterials.  Though consumer products like paints and 
coatings don’t have the same likelihood of exposure as PCPs meant to be 
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applied to the skin, they still have environmental implications, perhaps 
even more so because they are less likely to experience treatment from 
WWTPs. 
7.2 PROBLEM STATEMENT 
TiO2 nanomaterials are specifically incorporated into coatings for 
automobiles.  There is also likely a fraction of TiO2 materials used as 
pigments in paints that are in the nano size range.  The regular application 
of paints and their weathering creates a large source of TIO2 nanomaterial 
releases to the environment.  This research project was intended to study 
a number of paints to determine the mass concentration of TiO2 in the 
paint.  This provided an idea of how much TiO2 might be applied during 
the painting of a surface.   
7.3 MATERIALS AND METHODOLOGY 
 7.3.1 Paint products.  Eight different paint type products were 
purchased in Arizona hardware stores in March and June 2011.  Different 
types of paints were selected including 3 sealers, 2 base paints, 2 white 
paints, and 1 glue.  White paint type products were chosen because they 
were expected to have higher TiO2 concentrations.   Samples were 
transported to the laboratory and stored in a clean, dry cupboard.  
Information about the products, including whether or not TiO2 was listed 
on the label was recorded. 
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7.3.2 Digestion.  500 mg of each product was weighed and added 
to a clean microwave digestion vessel.  The products were then 
microwave digested with 2 mL HF and 8 mL HNO3 to break down the 
organic matter and the TiO2.  This method is described in detail in Chapter 
3.  It is important for the paint and sealer products that the products were 
not allowed to dry into the vessels before acid was added.  Some of the 
products with a large amount of organics were not totally broken down by 
the initial 2 mL of hydrogen peroxide added after digestion.  As the liquid 
was evaporated, if it became apparent that there was organic material 
remaining in the sample, the sample was cooled and then 2 mL of 
hydrogen peroxide was added and the sample was heated again.  It is 
important to note that samples with high concentrations of Ti will turn 
orange with the addition of peroxide in an acidic environment. [83] (See 
Appendix D, Photo D.8).  Ti was quantified using the same ICP-MS 
analysis procedure detailed in Chapter 3.  All samples with Ti 
concentrations outside of the calibration range were diluted and re-
analyzed.  A study using a similar method of acid digestion for Ti 
quantification in sunscreens demonstrated a recovery of 95%. [85] A 
recovery evaluation for TiO2 nanoparticles and microparticles was 
conducted in Chapter 5.  
7.4 RESULTS 
 7.4.1 Total TiO2 in paints.  All 8 paint type products were digested 
and the concentration of TiO2 (determined as Ti) in the products were 
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determined.  Three of the products were digested in triplicate.  The 
triplicates were in good agreement, all within 20%.  The highest 
concentration of Ti in any product was found in the Benjamin Moore White 
paint at 114 μg/mg.  The Ace brand paint had a similar concentration.  All 
three sealant products had similar concentrations which were high, but an 
order of magnitude lower than the white paints.  The two base paint 
samples and the glue had concentrations that were 2 orders of magnitude 
lower than then sealants.  The results for the total titanium concentration 
for all the paint type products can be seen in Figure 7.1. 
 
Figure 7.1. Total titanium concentration for paint type products.  Error bars 
represent the standard deviation from samples digested in triplicate. 
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7.5 DISCUSSION 
 The TiO2 concentration in the white paint products and the sealers 
was generally higher than the concentrations seen in foods and PCPs.  
This is because such a large amount of TiO2 is added to the paints and 
sealers to create and maintain a bright white color after application.  The 
base paints contained a lower concentration of TiO2 because though they 
are white when they are purchased, they are intended to have other colors 
mixed into the paint.  Therefore, there is less need to have TiO2 to provide 
bright white coloring.  Elmer’s glue is white in the bottle, but is intended to 
dry clear, meaning there is less need for TiO2 as a pigment. 
7.6 SUMMARY 
 White paints had the highest concentrations of Ti with Benjamin 
Moore being the highest at 113.7 µg Ti/mg. 
 The Ti concentration in the sealer products was less than half of 
that in the white paints, with gripper sealer being the highest at 40.7 
µg Ti/mg. 
 The base paints and Elmer’s glue had Ti concentrations greater 
than 2 orders of magnitude lower than the paints and sealers with 
one Behr base paint having the highest concentration at 0.22 µg 
Ti/mg. 
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CHAPTER 8: SYNTHESIS OF FINDINGS AND RECOMMENDATIONS 
8.1 INTRODUCTION 
 As TiO2 nanomaterial use has increased in recent years it is 
important to understand the implications of the nanomaterials on human 
health.  The development of a pharmacokinetic model aids in the 
prediction of TiO2 tissue concentrations resulting from different exposure 
methods and dosages.  However, the resulting concentrations are only 
modeled.  In order to verify the results, empirically, a method had to be 
developed that can digest tissue and recover the entirety of the TiO2 in the 
tissue.  Microwave digestion of samples with nitric and hydrofluoric acid 
proved to be an efficient method for rapid quantification of the TiO2.  The 
digestion method was then used to quantify the deposition of various TiO2 
nanomaterials instilled into rat lungs.  The results of the instillation project 
provide more information for the model, specifically about deposition and 
clearance rates of different kinds of TiO2 nanomaterials.  The digestion 
method was also robust enough to be used to digest food products and 
consumer products.  Digesting the foods allowed for measurement of the 
total TiO2 in foods and PCPs as well as determination of the nano sized 
fraction of TiO2.  The data gained from those studies can be used to 
determine realistic dose inputs for exposure by ingestion. 
 TiO2 nanomaterials not only have implications for human health, but 
for releases to the environment and their impacts.  The excretion 
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information from the pharmacokinetic model can be used with the data 
from the TiO2 food project to determine estimates of the mass of nano 
TiO2 that can enter wastewater from human waste.  The data from the 
TiO2 PCP study can be used to determine estimate of the mass of nano 
TiO2 that can enter wastewater from the use of products like sunscreen 
and toothpaste.  The digestion method could also be applied for a study of 
TiO2 nanomaterials in wastewater. 
8.2 SUMMARY OF FINDINGS 
 8.2.1 Pharmacokinetic modeling of TiO2 nanomaterials.  It is the 
purpose of this project to develop a pharmacokinetic ADME model for TiO2 
nanomaterials that can predict tissue concentrations based on an 
exposure level. 
 Inhalation is the most important exposure route for human health 
implications of TiO2 nanomaterials. 
 TiO2 nanomaterials are more slowly cleared from the lungs than 
larger particles and have greater toxic effects with the half-life being 
as high as 501 days. 
 TiO2 nanomaterials may distribute to the lymphatic system, brain, 
kidneys, liver, and spleen.  Modeled liver concentrations were 
generally highest, as much as 3.3 μg/g after inhalation. 
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 Primary particle size plays an important role in the ADME of 
particles as dose crystal structure, surface coating, and charge. 
 Extremely small TiO2 nanomaterials (< 5nm diameter) are excreted 
by the kidneys through the urine. 
 Larger TiO2 nanomaterials (~25 nm) are more likely to be excreted 
in bile from the liver. 
8.2.2 TiO2 quantification method development.  The purpose of 
this project is to develop a quantification method consisting of a digestion 
procedure and analysis procedure capable of accurately measuring TiO2 
at widely varying concentrations.   
 The digestion method degraded organic material enough that the 
samples could be analyzed by ICP without damaging the 
instruments. 
 The digestion method had greater than 86% recovery of Ti. 
 ICP-MS was the best choice for quantifying Ti because the 
detection limit of 164 ng/L was lower than ICP-OES detection limit. 
 Ti isotope 49 m/z is the best isotope to monitor because it has the 
least interferences from other species like P-O and S-O complexes. 
 The MDL for the digestion method was 1 μg TiO2. 
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8.2.3 TiO2 nanomaterial morphology effect on deposition and 
clearance in rat lungs.  This project intended to study how three different 
morphologies of TiO2 nanomaterials—anatase nanoparticles, rutile 
nanoparticles, and nanobelts—affected the deposition into the lungs of 
rats after intratracheal instillation, and the clearance rate of the particles 1 
day and 1 week after instillation by collaborators at UC-Davis.   
 Anatase TiO2 nanoparticles deposited in rat lungs to a greater 
degree than rutile nanoparticles or nanobelts with an average of 41 
µg of Ti found in caudal lobes 1 day after exposure to anatase TiO2.  
This was 218% higher than the second highest average 
concentration. 
 The anatase TiO2 nanoparticles were also found at the highest 
concentration in the caudal lobes with 1236 ng Ti/mg dry tissue as 
the average. 
 TiO2 nanoparticles concentration  were found to be 58% higher in 
caudal lobes than in the cranial lobes for anatase TiO2.  Similar 
trends were observed for all morphologies. 
 There was no significant evidence that there was less TiO2 material 
in the lung 7 days after instillation when compared to 1 day after 
instillation for all morphologies.   The Ti concentration had 
increased beyond the 80% confidence interval level for nanobelts 
from day 1 to day 7. 
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 The Ti lung concentrations from the digestion of the lungs showed 
an R2 agreement of 0.376 with cell inclusion counts conducted with 
microscopy. 
8.2.4 Nanoscale fraction of TiO2 used in food products.  This 
research project intended to study a number of foods with and without 
TiO2 listed as an ingredient to determine if TiO2 is present.  The total TiO2 
was quantified to understand the total TiO2 mass a person may be 
exposed to from a normal diet.  The smallest particles were isolated and 
quantified. 
 Foods that had the highest measured concentrations of TiO2 were 
those that were bright white, or those with a candy shell.  The 
highest concentration in any food was Dickinson’s Coconut Curd at 
3.59 μg/mg 
 TiO2 was found in foods at concentrations high enough that a 
person could ingest greater than 100 mg from a single serving.  
Hostess Powdered Donnettes had the highest mass from a single 
serving with 205 mg Ti. 
 Many foods did not list TiO2 as an ingredient, but still had relatively 
high concentrations of TIO2. 
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 3.9% of Ti particles were small enough to pass through a 0.45 μm 
filter for Dentyne Ice gum, with 5 different foods having greater than 
1% passage. 
8.2.5 Nanosized TiO2 used in PCPs.  This research project 
intended to study a number of PCPs with and without TiO2 listed as an 
ingredient to determine the mass concentration of TiO2 in the consumer 
products.  This gave an idea of how much TiO2 a person may use from 
normal application of the PCPs.  The smallest particles were isolated and 
quantified.   
 Sunscreens that had TiO2 listed as an ingredient had the highest 
concentrations of Ti with Neutrogena Sensitive Skin Sunblock being 
the highest with 70.1 ug Ti/mg. 
 All toothpastes had similar Ti concentrations, between 0.75 and 
5.64 ug Ti/mg. 
 PCPs that did not list TiO2 as an ingredient had Ti concentrations 
that were several orders of magnitude lower than those products 
with TiO2 listed as an ingredient with none being higher than 0.12 
ug Ti/mg. 
 6.3% of the total Ti measured in Neutrogena Pure and Free Baby 
was able to pass through a 0.45 μm filter indicating a larger portion 
of small near-nanosized particles. 
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 Less than 1% of the total Ti in the toothpastes was able to pass 
through a 0.45 μm filter.Less than 1% of the total Ti in the 
toothpastes was able to pass through a 0.45 μm filter. 
8.2.6 Nanosized TiO2 used in paints.  This research project 
intended to study a number of paints to determine the mass concentration 
of TiO2 in the paint.  This gave an idea of how much TiO2 might be applied 
during the painting of a surface.  The smallest particles were isolated and 
quantified.  
 White paints had the highest concentrations of Ti with Benjamin 
Moore being the highest at 113.7 µg Ti/mg. 
 The Ti concentration in the sealer products was less than half of 
that in the white paints, with gripper sealer being the highest at 40.7 
µg Ti/mg. 
 The base paints and Elmer’s glue had Ti concentrations greater 
than 2 orders of magnitude lower than the paints and sealers with 
one Behr base paint having the highest concentration at 0.22 µg 
Ti/mg. 
8.3 SYNTHESIS OF FINDINGS 
 8.3.1 Individual uptake.  Since the mass of Ti from a single 
serving can approach 100 mg, a person could easily ingest 500 mg of 
TiO2 in one day.  If 2% of those TiO2 particles are in the nano size range, 
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which is a reasonable assumption depending on the types of foods 
ingested, than a person may ingest 10 mg of TiO2 nanosized particles per 
day.  If a person ingested a larger amount of candies with hard shells like 
M&Ms and Good and Plenty, it is not unreasonable to assume that a 
person may ingest as much as 1 gram of TiO2 per day.  In candies with 
hard shells there is a greater fraction of nanosized TiO2 particles.  If 4% of 
the particles are in the nanosized range, then a person may ingest as 
much as 40 mg of nanosized TiO2 per day.  For a person weighing 70 kg, 
ingesting 40 mg of TiO2 nanomaterials results in an ingestion dose of 0.57 
mg/kg per day.  By using this data as an input for the ADME model 
developed in Chapter 2, and assuming the particles have an average 
diameter of 25 nm, the resulting concentrations in the kidney, liver, and 
spleen 14 days after ingestion are 0.043, 0.012, and 0.066 ng TiO2/g 
tissue respectively.  These tissue concentrations are very low compared to 
the concentrations that may result from the inhalation of TiO2 
nanomaterials (See Chapter 2).  In addition to the intentional ingestion of 
food, there may be accidental ingestion of PCPs such as sunscreen or 
toothpaste.  If as little as 0.5 g of Sensodyne toothpaste is ingested by 
accident it can results in 2.8 mg of Ti ingestion. Ingesting 0.5 g of 
Neutrogena Sensitive Skin Sunblock would cause the ingestion of 35 mg 
Ti with 2.1 mg of the Ti particles being in the nanosized range. 
 Though only the lungs of the rats from Chapter 4 were analyzed for 
TiO2, one can predict the TiO2 concentration in the other tissues using the 
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ADME model from Chapter 2.  The average concentration of anatase TiO2 
deposited into the caudal lobes after 1 day was selected as an input for 
the ADME model because it was the highest concentration found in any 
lung lobe leading to the highest concentrations in other tissues.  
Extrapolating the normalized concentration for the whole lung tissue, it can 
be expected that 0.3 mg of TiO2 would deposit into the lungs.  This leads 
to a TiO2 concentration in the kidney, liver, and spleen 14 days after 
instillation of 0.001, 0.01 and 0.003 μg TiO2/g tissue respectively.  These 
concentrations are nearly an order of magnitude higher than those 
resulting from daily ingestion of food predicted above.  The dermal 
absorption of sunscreen is unlikely to cause any relevant uptake of TiO2. 
 8.3.2 Societal and environmental applications. Although 
ingestion of TiO2 or dermal absorption did not cause widespread 
distribution throughout the body, the ingestion of foods and use of PCPs 
can still have important implications.  It is recommended that 2 mg of 
sunblock per square inch of exposed skin be applied.  However, a study of 
the application patterns of randomly selected individuals over 4.5 years 
showed that the median applied amount was 1.5 g/day. [144] Eventually 
this sunscreen is washed off and mixes with the wastewater.  If the 
sunscreen used was a TiO2 based sunscreen, 1.5 g/day of sunscreen 
would generate 105 mg TiO2/day and 6.3 mg nanosized TiO2/day as 
waste.  It was described above how a typical person will ingest 10 mg 
nanosized TiO2/day.  Since little of this is absorbed and distributed 
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through the body, nearly all of it would pass through the digestive system 
and leave the body as waste.  In this manner, from a typical diet and the 
use of sunscreen, an individual may be responsible for as much 16 mg of 
nanosized TiO2/day in wastewater.  Assuming an individual produces 120 
gal sewage/day, the wastewater would have an average concentration of 
13.8 μg/L of TiO2 small enough to pass through a 0.45 μm filter.  Though 
this sewage will go through treatment, as much as 4% of the total Ti in the 
influent is not removed and is released to the environment. [47] TiO2 may 
also bypass WWTPs.  This can occur when paint weathers and TiO2 
mixes with storm water or from PCPs washing off during recreational use 
and mixing with surface water. 
8.4 CONCLUSIONS 
 8.4.1 Pharmacokinetics of TiO2 nanomaterials.  Pulmonary 
absorption is the most relevant exposure route for TiO2 nanomaterials.  
Because of the enhanced toxicity of nanoscale TiO2 materials, individuals 
who regularly work with TiO2 nanomaterials in their workplace and are 
likely to inhale large quantities should be monitored for toxic effects or 
potentially for TiO2 nanomaterials in the urine or blood. 
 8.4.2 TiO2 digestion method.  Microwave digestion with HF and 
HNO3 provided good recovery of Ti materials.  The method was robust 
enough to digest complex matrices and had low interferences allowing for 
the quantification of trace amounts of Ti.  The method has the added 
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advantage of being capable of rapid digestion and analysis of samples.  
Other digestion methods using sulfuric acid or ICP-OES should be used 
sparingly. 
 8.4.3 TiO2 nanomaterial morphology effects on deposition and 
clearance.   When the enhanced toxicity of anatase TiO2 nanomaterials is 
coupled with their apparent higher deposition rates, the threat to human 
health is far greater for airborne anatase TiO2 nanomaterials.  This is an 
important consideration for policy makers.  The enhanced threat from the 
production of pure anatase TiO2 nanomaterials may cause anatase 
production processes to be regulated differently than rutile production 
processes. 
 8.4.4 Individual Uptake.  An individual could ingest 10 mg of TiO2 
nanomaterials from a typical diet and even more if a person’s diet 
consisted of candies or highly processed white foods.  However, the 
uptake of these nanomaterials is minimal and not a large threat to human 
health.  The exception is for those individuals with preexisting GI diseases 
such as Crohn’s disease.  A diet minimizing microparticles and 
nanoparticles is recommended for individuals with Crohn’s disease.  The 
results of this study have shown that the ingredient listings on foods are 
not always a good indicator of whether they include TiO2. 
 8.4.5 Societal and Environmental Implications.  The ingestion of 
foods and application of PCPs containing TiO2 can result in 16 mg nano 
126 
 
TiO2/day introduced to the wastewater for each individual.  As the 
production and use of TiO2 nanomaterials increases the amount of TiO2 in 
the wastewater will increase.  This will likely cause an increased 
concentration of TiO2 nanomaterials in the biosolids from WWTPs that are 
land applied as well as the treated effluent waters, both of which allow a 
greater loading of TIO2 nanomaterials to the environment. 
8.5 FUTURE WORK RECOMMENDATIONS 
 The results derived from the ADME model could be further verified 
by a study monitoring the feces and/or urine to complete a mass balance 
based on inputs like inhalation and ingestion and excreted outputs.  The 
model could also be expanded to other tissues in the body by using the 
digestion method detailed in this work.  It would be beneficial to have more 
data for different sizes of nanoparticles to create a continuum of 
distributions based on nanoparticle diameter rather than only being able to 
model two TiO2 nanoparticle sizes.  More data on clearance rates for 
different types of TIO2 nanomaterials could be garnered for the model from 
another morphology inhalation study that monitored the animals for a 
greater time after instillation and harvested other organs to generate 
tissue concentration data. 
 The synthesis of the findings had suggested a large amount of 
nanosized TiO2 may be entering the wastewater.  TiO2 nanomaterials in 
wastewater could be monitored to verify the findings by sampling 
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wastewater influents at different WWTPs and using the separation and 
digestion methods in this thesis.  Furthermore, the digestion method could 
be modified to be used for other types of samples like biosolids or soil 
samples.  Digesting biosolids could be used to monitor how the 
concentration of TiO2 nanomaterials may be changing.  Since biosolids 
are often land applied for agriculture, soil samples with biosolids applied 
could be compared to control soil samples to determine whether TiO2 
nanomaterials may be a relevant cause of concern for agricultural 
production.  It would also be beneficial to study how TiO2 nanosized 
particles from foods and PCPs change by aggregation or coating of the 
surface in wastewater or environmental matrices. 
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APPENDIX A 
SUPPLEMENTARY INFORMATION 
 
  
144 
 
Table A.1 
Digestion Reagent Concentrations 
Reagent Concentration Titanium 
Nitric Acid 70% by weight < 10 pg/g 
Hydrofluoric Acid 50% by weight < 5 pg/g 
Hydrogen Peroxide 30% by weight   
 
Table A.2 
Passing Performance Report Requirements  
Sensitivity and Stability Results 
Species 7 Li 115 In 220 Bkg 238 U 
Mean CPS > 60,000 > 400,000 < 3 > 800,000 
% RSD < 2.0 % < 2.0 % N/A < 2.0 % 
Ratio Results 
Ratio 137 Ba++/137 Ba 115 In/220 Bkg 156 CeO/140 Ce   
Limit < 0.0300 < 800,000 < 0.0200   
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Figure A.1.  Normalized titanium concentration for all foods. 
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Figure A.2.  Mass titanium per serving of food.  Red bars indicate TiO2 was listed as an ingredient.  Green 
bars indicate foods were below the detection limit.
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APPENDIX B 
STANDARD OPERATING PROCEDURES 
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B.1 TiO2 Nanoparticle Stock Preparation 
1. Add .6 grams of TiO2 nanoparticle (NP) powder to 600 mL of 
nanopure water. 
2. Sonicate the NP solution for 30 min at 100% amplitude (30 sec on 
and 5 sec off). 
a. Add ice around the beaker while sonicating to prevent 
overheating. 
b. Watch the power reading on the instrument.  At 100% 
amplitude it should read approximately 120 W.  This 
provides 200W/L of power. 
3. Add 50 mL of the sonicated NP solution to each of eight 50 mL 
centrifuge vials. 
4. Centrifuge the sonicated NP solution for 30 min at 3000 RCF. 
5. Carefully remove the vials from the centrifuge and pipette off the 
top 30 mL of the solution from each vial without disturbing the 
bottom. 
a. Any solution remaining in the centrifuge vials can be 
combined and re-sonicated. 
6. Run phase analysis light scattering (PALS) on the centrifuged NP 
solution to determine particle size.  (For P25 TiO2 NPs, the effective 
diameter should be ~50 nm) 
7. If the particle size is not sufficiently small, centrifuge again and run 
PALS again.  
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B.2 TiO2 Microwave Digestion in Tissues and other Organic Matrices 
 Hydrofluoric acid will be used in this method, make sure you are 
properly trained and have all required notifications posted near your 
workspace. 
 All work using acids should be done in the hood. 
 All digestion vessels, Teflon, and glassware should be sonicated in 
an acid bath for at least 10 minutes to clean. 
 
1. Add tissue or sample volume to microwave digestion vessel. 
Note: No more than 0.5 g of organics can be digested at a 
time. 
2. If tissues must be dried first, weigh the empty vessel, dry the tissue 
at 80°C till weight loss no longer occurs (12-18 hours) and record 
the new weight. 
3. Add 8 mL nitric acid and 2 mL of HF to each vessel. 
4. Replace the stopper and tighten the lids as tight as possible! 
5. Place the vessels in the microwave digestor carousel. 
6. Place the carousel in the microwave and choose the proper method 
then press start/run. 
7. Allow >20 min after the method has finished for the vessels to cool. 
8. Remove the vessels from the carousel. 
9. Carefully unscrew the lids from each vessel.  Pressure will have 
built up causing a small burst of gas to escape upon opening. 
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10. Rinse each vessel with 2% nitric acid 3 or 4 times into a Teflon 
beaker. (About 30 mL of rinse) 
11. Heat the beakers on a hotplate at 180°C for approximately 3-4 
hours. 
Note: Do not heat the Teflon beakers over 220°C. 
12. Continue heating until the remaining liquid is between 0.1-0.5 mL. 
13. Remove from heat and allow the beaker to cool. 
14. Rinse the beaker 3 or 4 times into a 25 mL volumetric flask with a 
2% nitric acid rinse. 
15. Continue filling the flask until it is to the 25 mL mark. 
16. Transfer the solution to a clean 50 mL centrifuge vial until ICP 
analysis can be done. 
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B.3 TiO2 Hotplate Digestion in Tissues and other Organic Matrices 
1. Tare each Teflon vessel individually and add the tissue sample 
recording the weight. 
2. Add 4 mL of concentrated ultrapure nitric acid and 8 mL of 
hydrogen peroxide. 
3. Cap with a ribbed watch glass and place on hot plate. 
4. Heat for 4 hrs at 120°C to degrade organics and evaporate acid.  
Do not go to total dryness. 
5. Cool and add 2 mL of ultrapure hydrofluoric acid. 
6. Heat at 80°C until remaining solution is between 0.1-0.5 mL. 
7. Remove from heat and cool solution. 
8. Add 2% nitric acid in nanopure and rinse the vessel 3+ times into a 
25mL acid-washed volumetric flask. 
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APPENDIX C 
MODEL DATA 
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Table C.1 
Exposure Scenario #1 Model 
INHALATION 
Input Value Unit Calculation Source 
Air Concentration 2 mg/m3 2   
Exposure Time 20 days 20   
Volume Inhaled/Day 9.6 m3/day 9.6   
Total Air Volume 192 m3 =D5*D4   
Particle Mass Inhaled 384 mg =D6*D3   
Mass Deposited in Alveoli 128 mg =D7/3 EPA 
Subject Mass 70 kg 70   
Inhalation Dose 1.8 mg/kg =D8/D9   
Mass Absorbed to Blood (10 min) 35.8 mg =D8*0.28 Choi 
Mass Absorbed to Blood Total 64 mg =D8*0.5 Choi 
Blood Volume 5 L 5   
Maximum Blood Concentration 12.8 ug/mL =D12/D13   
Lymph Node Conc. (10 min) 0.72 mg/g =D11*0.02 Choi 
Lymph Node Conc. (30 min) 1.28 mg/g =D12*0.02 Choi 
Mass Cleared by Urine 9.28 mg =D12*0.145 Choi 
Maximum Kidney Concentration 66.29 ug/g =D17/140*1000   
Brain Concentration Negligible ug/g Negligible Wang 
Liver Concentration Negligible ug/g Negligible Choi 
Spleen Concentration Negligible ug/g Negligible Choi 
Days Post Exposure 132 days 132   
Mass Remaining in Lungs 64 mg 
=D8*(1/2) 
^(D22/132) 
Berm-
udez 
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Table C.2 
Exposure Scenario #2 Model for Inhalation 
INHALATION 
Input Value Unit Calculation Source 
Air Concentration 2.5 mg/m3 2.5   
Exposure Time 3 days 3   
Volume Inhaled/Work Day 9.6 m3/day 9.6   
Total Air Volume 28.8 m3 =D5*D4   
Particle Mass Inhaled 72 mg =D6*D3   
Mass Deposited in Alveoli 36 mg =D7/2 EPA 
Subject Mass 70 kg 70   
Inhalation Dose 0.5 mg/kg =D8/D9   
Mass Absorbed to Blood 8.64 mg =D8*0.24 Geiser 
Blood Volume 5 L 5   
Maximum Blood Concentration 1.7 ug/mL =D11/D12   
Mass in Lymphatic System 
(100 days) 1.1 mg =5/170*D8 Oberdorster 
Kidney Concentration (1 day) 0.02 ug/g =D10/5*0.24*0.67 Fabian 
Kidney Concentration (14 days) 0.00 ug/g =D10/5*0.24*0.2 Fabian 
Kidney Concentration (28 days) 0.00 ug/g =D10/5*0.24*0.2 Fabian 
Liver Concentration (1 day) 3.3 ug/g =133.8*0.24*D10/5 Fabian 
Liver Concentration (14 days) 2.5 ug/g =99.5*0.24*D10/5 Fabian 
Liver Concentration (28 days) 2.7 ug/g =111.3*0.24*D10/5 Fabian 
Spleen Concentration (1 day) 1.9 ug/g =78.7*0.24*D10/5 Fabian 
Spleen Concentration (14 days) 1.2 ug/g =48.8*0.24*D10/5 Fabian 
Spleen Concentration (28 days) 0.8 ug/g =33.3*0.24*D10/5 Fabian 
Brain Concentration (1 day) 1.23 ng/g =D10/50*120 Wang 2008 
Days Post Exposure 501 days 501   
Mass Remaining in Lungs 18 mg 
=D8*(1/2)^ 
(D25/501) Oberdorster 
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Table C.3 
Exposure Scenario #2 Model for Ingestion and Inhalation 
INGESTION 
Input Value Unit Calculation Source 
Subject Mass 70 kg 70  
Ingestion Dose 5.0 mg/kg 5.0  
Mass Absorbed to Blood 2.8 mg =D3*I4*0.008 Wang 
Blood Volume 5 L 5  
Maximum Blood Concentration 0.6 ug/mL =I5/I6  
Kidney Concentration (14 days) 0.375 ng/g =D4/5000*375 Wang 
Liver Concentration (14 days) 0.107 ng/g =D4/5000*106.7 Wang 
Spleen Concentration (14 days) 0.580 ng/g =D4/5000*580 Wang 
Brain Concentration (1 day) 0.15 ng/g =I4/5000*150 Wang 
 
INJECTION 
Input Value Unit Calcualtion Source 
Subject Mass 70 kg 70   
Injection Dose 5.0 mg/kg 5.0   
Mass Absorbed to Blood 350 mg =M3*M4   
Blood Volume 5 L 5   
Maximum Blood Concentration 70.0 ug/mL =M5/M6   
Kidney Concentration (1 day) 0.67 ug/g =M4/5*0.67 Fabian 
Kidney Concentration (14 days) 0.20 ug/g =M4/5*0.2 Fabian 
Kidney Concentration (28 days) 0.20 ug/g =M4/5*0.2 Fabian 
Liver Concentration (1 day) 133.8 ug/g =133.8*M4/5 Fabian 
Liver Concentration (14 days) 99.5 ug/g =99.5*M4/5 Fabian 
Liver Concentration (28 days) 111.3 ug/g =111.3*M4/5 Fabian 
Spleen Concentration (1 day) 78.7 ug/g =78.7*M4/5 Fabian 
Spleen Concentration (14 days) 48.8 ug/g =48.8*M4/5 Fabian 
Spleen Concentration (28 days) 33.3 ug/g =33.3*M4/5 Fabian 
Brain Concentration (1 day) 0.10 ng/g =M4/5000*100 Zhang 
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APPENDIX D 
PHOTOGRAPHS 
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D.1 Rat Lung Photographs 
 
Figure D.1.  Caudal lobe sample. 
 
Figure D.2.  Caudal lobe in a microwave digestion vessel before drying 
(left) and after drying (right). 
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Figure D.3.  MARS Express microwave digestor. 
 
Figure D.4.  Microwave vessels and Teflon beakers on a hotplate. 
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Figure D.5. Rat lung sample after digestion and evaporation 
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Figure D.6.  Microwave vessel after digestion of dairy product. 
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Figure D.7. Animal P1221 broncoalveloar lavage cells with TiO2 nanobelt 
inclusions.  Shown at 40x. 
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D.2 Food Product Photographs 
 
Figure D.8. 0.45 μm nylon filter after filtering organics from a food sample. 
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D.3 Consumer Products Photographs 
 
Figure D.9.  Digested sunscreen. 
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APPENDIX E 
METHOD DETECTION LIMITS 
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E.1 Purpose 
 Several tests were done to determine how digestion, matrix effects, 
and analysis instrument choice affect the recovery of nanoparticle 
solutions.  Instrument detection limits (IDLs) for the ICP-OES and ICP-MS 
instruments were determined for Ti, Zn, and gold (Au).  More on the IDL 
for Ti can be found in Chapter 3.  Then solutions of TiO2 and ZnO 
nanoparticles were prepared at magnitudes ranging from 10 µg/L (ppb) to 
100 mg/L (ppm) in various environmentally and biologically relevant 
matrices.  The solutions were then analyzed with and without digestion by 
both ICP-OES and ICP-MS.  The digestion method used was a hot plate 
digestion utilizing nitric and sulfuric acid rather than the microwave 
digestion with HF as described in Chapter 3. 
E.2 Instrument Detection Limit 
Test Concentration ICP-MS ICP-OES 
Titanium (2 μg/L) 81 ng/L 562 ng/L 
Titanium (5 μg/L) 164 ng/L 491 ng/L 
Zinc (2 μg/L) 414 ng/L 1950 ng/L 
Zinc (5 μg/L) 616 ng/L 3690 ng/L 
Gold (2 μg/L) 97 ng/L N/A 
Gold (5 μg/L) 349 ng/L N/A 
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E.3 ICP-MS Ti Instrument Detection Limit Data 
Test concentration = 0.002 mg/L 
   
       Sample # C (ppb) 
 
n 10 
  1 2.080 
 
Average 2.09238 
  2 2.099 
 
Variance 0.00082 
  3 2.059 
 
StDev 0.02867 
  4 2.074 
 
    
  5 2.045 
 
t (n-1, 0.01) 2.821 
  6 2.090 
 
t value for 99% at n (from Table) 
 7 2.103 
     8 2.115 
 
MDL (ppb) 0.081 
  9 2.133 
 
t value * StDev 
  10 2.127 
     
   
  X2/df 
(X2/df) 
(MDL) 
 
   
LCL 0.300 0.024 
 
   
UCL 2.114 0.171 
 
       
    
Average MDL 0.122 
Test concentration = 0.005 mg/L 
 
LCL 0.037 
     
UCL 0.259 
       Sample # C (ppb) 
 
n 10 
  1 5.479 
 
Average 5.52640 
  2 5.456 
 
Variance 0.00338 
  3 5.427 
 
StDev 0.05816 
  4 5.551 
 
    
  5 5.533 
 
t (n-1, 0.01) 2.821 
  6 5.515 
 
t value for 99% at n (from Table) 
 7 5.587 
     8 5.538 
 
MDL (ppb) 0.164 
  9 5.611 
 
t value * StDev 
  10 5.567 
     
   
  X2/df 
(X2/df) 
(MDL) 
 
   
LCL 0.300 0.049 
 
   
UCL 2.114 0.347 
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E.4 ICP-OES Ti Instrument Detection Limit Data 
Test concentration = 0.002 mg/L 
  
      Sample # C (ppb) 
 
n 10 
 1 1.821 
 
Average 1.89582 
 2 1.872 
 
Variance 0.03967 
 3 2.164 
 
StDev 0.19917 
 4 1.814 
 
    
 5 2.158 
 
t (n-1, 0.01) 2.821 
 6 1.940 
 
t value for 99% at n (from Table) 
7 2.021 
    8 1.967 
 
MDL (ppb) 0.562 
 9 1.658 
 
t value * StDev 
 10 1.544 
    
   
  X2/df (X2/df) (MDL) 
   
LCL 0.300 0.169 
   
UCL 2.114 1.188 
      Test concentration = 0.005 mg/L 
  
      
      Sample # C (ppb) 
 
n 10 
 1 4.869 
 
Average 5.03428 
 2 5.079 
 
Variance 0.03031 
 3 5.143 
 
StDev 0.17411 
 4 5.259 
 
    
 5 4.993 
 
t (n-1, 0.01) 2.821 
 6 4.958 
 
t value for 99% at n (from Table) 
7 5.119 
    8 5.296 
 
MDL (ppb) 0.491 
 9 4.794 
 
t value * StDev 
 10 4.834 
    
   
  X2/df (X2/df) (MDL) 
   
LCL 0.300 0.147 
   
UCL 2.114 1.038 
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E.5 ICP-MS Zn Instrument Detection Limit Data 
Test concentration = 0.002 mg/L 
   
       Sample # C (ppb) 
 
n 10 
  1 2.917 
 
Average 3.04204 
  2 2.887 
 
Variance 0.02158 
  3 2.883 
 
StDev 0.14690 
  4 2.890 
 
    
  5 3.028 
 
t (n-1, 0.01) 2.821 
  6 3.257 
 
t value for 99% at n (from Table) 
 7 3.140 
     8 3.023 
 
MDL (ppb) 0.414 
  9 3.215 
 
t value * StDev 
  10 3.181 
     
   
  X2/df 
(X2/df) 
(MDL) 
 
   
LCL 0.300 0.124 
 
   
UCL 2.114 0.876 
 
       
    
Average MDL 0.515 
Test concentration = 0.005 mg/L 
 
LCL 0.155 
     
UCL 1.089 
       Sample # C (ppb) 
 
n 10 
  1 3.583 
 
Average 4.08918 
  2 3.810 
 
Variance 0.04764 
  3 4.219 
 
StDev 0.21827 
  4 4.135 
 
    
  5 4.243 
 
t (n-1, 0.01) 2.821 
  6 4.155 
 
t value for 99% at n (from Table) 
 7 4.247 
     8 4.148 
 
MDL (ppb) 0.616 
  9 4.131 
 
t value * StDev 
  10 4.221 
     
   
  X2/df 
(X2/df) 
(MDL) 
 
   
LCL 0.300 0.185 
 
   
UCL 2.114 1.301 
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E.6 ICP-OES Zn Instrument Detection Limit Data 
Test concentration = 0.002 mg/L 
  
      
      Sample # C (ppb) 
 
n 10 
 1 1.755 
 
Average 2.26538 
 2 2.371 
 
Variance 0.47689 
 3 3.704 
 
StDev 0.69057 
 4 2.792 
 
    
 5 2.842 
 
t (n-1, 0.01) 2.821 
 6 1.990 
 
t value for 99% at n (from Table) 
7 1.933 
    8 1.696 
 
MDL (ppb) 1.948 
 9 1.357 
 
t value * StDev 
 10 2.213 
    
   
  X2/df 
(X2/df) 
(MDL) 
   
LCL 0.300 0.584 
   
UCL 2.114 4.117 
      Test concentration = 0.005 mg/L 
  
      
      Sample # C (ppb) 
 
n 10 
 1 6.626 
 
Average 4.69395 
 2 4.240 
 
Variance 1.70603 
 3 4.803 
 
StDev 1.30615 
 4 5.710 
 
    
 5 2.509 
 
t (n-1, 0.01) 2.821 
 6 5.918 
 
t value for 99% at n (from Table) 
7 4.208 
    8 5.097 
 
MDL (ppb) 3.685 
 9 5.029 
 
t value * StDev 
 10 2.800 
    
   
  X2/df 
(X2/df) 
(MDL) 
   
LCL 0.300 1.105 
   
UCL 2.114 7.788 
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E.7 ICP-MS Au Instrument Detection Limit Data 
Test concentration = 0.002 mg/L 
  
      Sample # C (ppb) 
 
n 10 
 1 1.927 
 
Average 2.01754 
 2 1.997 
 
Variance 0.00118 
 3 2.028 
 
StDev 0.03429 
 4 2.035 
 
    
 5 2.035 
 
t (n-1, 0.01) 2.821 
 6 2.037 
 
t value for 99% at n (from Table) 
7 2.021 
    8 2.023 
 
MDL (ppb) 0.097 
 9 2.031 
 
t value * StDev 
 10 2.042 
    
   
  X2/df 
(X2/df) 
(MDL) 
   
LCL 0.300 0.029 
   
UCL 2.114 0.204 
      Test concentration = 0.005 mg/L 
  
      
      Sample # C (ppb) 
 
n 10 
 1 4.776 
 
Average 5.00383 
 2 4.849 
 
Variance 0.01533 
 3 4.895 
 
StDev 0.12383 
 4 4.977 
 
    
 5 5.111 
 
t (n-1, 0.01) 2.821 
 6 5.101 
 
t value for 99% at n (from Table) 
7 5.116 
    8 5.110 
 
MDL (ppb) 0.349 
 9 5.065 
 
t value * StDev 
 10 5.038 
    
   
  X2/df 
(X2/df) 
(MDL) 
   
LCL 0.300 0.105 
   
UCL 2.114 0.738 
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E.8 Nitric/Sulfuric Acid Digestion of TiO2 and ZnO in Nanopure 
 
Figure E.1. TiO2 analyzed by ICP-OES in a nanopure water matrix.
 
Figure E.2. TiO2 analyzed by ICP-MS in a nanopure water matrix. 
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Figure E.3. ZnO analyzed by ICP-OES in a nanopure water matrix. 
 
Figure E.4. ZnO analyzed by ICP-MS in a nanopure water matrix. 
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E.8.1 Nanopure Summary.  
 TiO2 samples analyzed by ICP-OES had similar results at higher 
concentrations regardless of whether the samples were digested or not.  
However, TiO2 samples analyzed by ICP-MS without digestion had a 
much lower measured concentration than expected when compared to 
those that were digested.  This is likely because a smaller fraction of the 
nebulized sample reaches the plasma in the ICP-MS compared to the 
ICP-OES, and larger, undigested nanoparticles or aggregates would be 
less likely to pass through the spray chamber to the plasma.  However, on 
both instruments, the digestion caused the measured concentration of the 
lowest sample to be nearly an order of magnitude higher.  This is because 
of interferences caused by the sulfuric acid matrix in the samples post-
digestion.  Thus, digestion is likely necessary to determine an accurate 
quantification, but another digestion method would be preferred. 
 There was little difference in the measured concentration of ZnO 
samples with or without digestion for more concentrated samples.  This is 
likely because ZnO will dissolve faster than titanium so digestion is not as 
necessary.  However, for the more dilute samples the digestion caused 
the measured concentration to be much higher than the expected 
concentration.  The 3 most dilute samples had nearly the same measured 
concentration regardless of the expected concentration.  This is because 
the sulfuric acid matrix caused interferences resulting in higher readings.  
These trends were observed for both instruments.  
174 
 
E.9 Nitric/Sulfuric Acid Digestion of TiO2 and ZnO in Moderately Hard 
Water 
 
Figure E.5. TiO2 analyzed by ICP-OES in a moderately hard water matrix. 
 
Figure E.6. TiO2 analyzed by ICP-MS in a moderately hard water matrix.  
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Figure E.7. ZnO analyzed by ICP-OES in a moderately hard water matrix. 
 
Figure E.8. ZnO analyzed by ICP-MS in a moderately hard water matrix.  
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E.9.1 Moderately Hard Summary 
 The analysis of TiO2 in moderately hard water showed less of a 
need for digestion when compared to nanopure water.  This could be 
because aggregates were more likely to form in nanopure than in the 
moderately hard water.  If the aggregation was less in the moderately hard 
water then the sample might be fully ionized in the plasma even without 
digestion.  A similar trend was observed to the nanopure water that the 
digestion technique caused false high readings for the most dilute 
samples. 
 Like the nanopure matrix, digestion seems to be less necessary for 
the ZnO in moderately hard water.  The one exception this time was that 
the most concentrated sample had a much lower recovery than expected 
on the ICP-MS.  When the ZnO samples were analyzed by ICP-MS there 
appeared to be an interference for the two most dilute samples.  Because 
the higher measured concentrations were observed for both the digested 
and undigested samples, the interference was probably caused by the 
matrix effect of the moderately hard water or the moderately hard water 
and the sulfuric acid rather than just the sulfuric acid. 
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E.10 Nitric/Sulfuric Acid Digestion of TiO2 and ZnO in Synthetic Urine 
 
Figure E.9. TiO2 analyzed by ICP-OES in a synthetic urine matrix. 
 
Figure E.10. TiO2 analyzed by ICP-MS in a synthetic urine matrix. 
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Figure E.11. ZnO analyzed by ICP-OES in a synthetic urine matrix. 
 
Figure E.12. ZnO analyzed by ICP-MS in a synthetic urine matrix.  
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E.10.1 Synthetic Urine Summary 
The analysis of TiO2 using ICP-OES again showed that digestion 
may not be necessary, the measured concentrations were similar and 
near the expected concentration.  Surprisingly, the most dilute samples 
did not have a noticeable interference from the acid digestion matrix.  This 
could be because the sulfate from the acid interacted with something in 
the synthetic urine and fell out of solution.  When using ICP-MS it is 
apparent that digestion is needed to get an accurate measurement of 
more concentrated samples.  However, for more dilute samples, both 
digested and undigested samples were measured higher than expected, 
with the digested samples more so.  This is probably because both the 
synthetic urine and sulfuric acid matrix are causing interferences. 
During analysis of ZnO the digested and undigested samples were 
in good agreement when analyzed by ICP-OES and the undigested 
samples had a higher measured concentration than the digested samples.  
The most dilute digested sample measured higher than expected on the 
ICP-OES cause of the sulfuric acid matrix.  The two most dilute samples 
(digested and undigested) were higher than expected likely because of 
interferences with the Zn mass isotope from the synthetic urine matrix. 
E.11 Detection Limit Summary 
 Digestion is not necessary for ZnO solutions unless at high 
concentrations.  However, digestion is necessary for TiO2 solutions 
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especially if analysis is being completed by ICP-MS which has lower 
detection limits.  The sulfuric acid matrix of the digested caused 
interferences at lower concentrations.  This was especially apparent when 
analysis was carried out by ICP-MS.  A different digestion method could 
minimize the interferences for both instruments.  However, there were 
interferences that arose from the moderately hard water and synthetic 
urine matrix even without any digestion.  These interferences cause a 
higher reading than the actual concentration.  Thus, it is important for any 
complex matrix to digest blanks in order to understand what interferences 
may arise. 
 
 
 
 
